Curriculum Vitae - Johns Hopkins University
CURRICULUM VITAE
Daniel E. Polsky, Ph.D., M.P.P.
PERSONAL DATA
Home Address:
604 Schiller Ave
Merion Station, PA 19066
Business Address:
Johns Hopkins Bloomberg School of Public Health
Department of Health Policy and Management
624 N. Broadway,
Baltimore, MD 21205
EDUCATION AND TRAINING
University of Pennsylvania School of Arts and Sciences, Philadelphia, PA
Ph.D., Economics, 1996
Doctoral Dissertation: “Changing Consequences of Job Separation in the United States”
University of Michigan, Gerald R. Ford School of Public Policy, Ann Arbor, MI
Master of Public Policy, 1989
University of Michigan, Ann Arbor, MI
B.A., Economics, 1996
Postdoctoral Training: None
Board Certification: None
PROFESSIONAL EXPERIENCE
Bloomberg Distinguished Professor of Health Policy and Management, Department of Health Policy and Management, Bloomberg School of Public Health, Johns Hopkins University, 2019 – present.
Bloomberg Distinguished Professor of Business, Carey School of Business, Johns Hopkins University, 2019 – present.
Professor of Medical Ethics and Health Policy, University of Pennsylvania School of Medicine, 2015 – 2019
Robert D. Eilers Professor in Health Care Management and Economics, University of Pennsylvania School of Medicine, 2012 – 2019
Executive Director, Leonard Davis Institute of Health Economics, University of Pennsylvania, 2012 – 2019
Professor of Medicine, University of Pennsylvania School of Medicine, 2009 - 2019
Professor of Health Care Management, The Wharton School, University of Pennsylvania, 2009-2012
Director of Research, Leonard Davis Institute of Health Economics, University of Pennsylvania, 2008-2012
Senior Economist, President’s Council of Economic Advisors, Washington, DC, 2007-2008
Associate Professor of Medicine, University of Pennsylvania School of Medicine, 2006-2009
Associate Professor of Health Care Management, The Wharton School, University of Pennsylvania, 2004-2009
Research Associate Professor of Medicine, University of Pennsylvania School of Medicine, 2002-2006
Senior Fellow, Leonard Davis Institute of Health Economics, University of Pennsylvania, 1997 - present
Research Assistant Professor of Medicine, University of Pennsylvania School of Medicine, 1996-2002
PROFESSIONAL ACTIVITIES
Society Membership and Leadership
Fellowship, The College of Physicians of Philadelphia, 2017 – present
Member, John Morgan Society, 2017 – present
Member, American Society of Health Economists, 2005 – present
Meeting host, 2016
Member, International Society for Pharmacoeconomics and Outcomes Research, 1999 - present
Member, International Health Economics Association, 1998 – present
Member, Society for Medical Decision Making, 1997 - present
Member, AcademyHealth, 1996 – present
Membership Committee, 2013 – 2017
Board of Directors’ Nominating Committee, 2017 – present
Member, American Economic Association, 1995 - present
Participation on Advisory Panels
National Institute of Health,
• National Institute on Aging, Special Emphasis Panel (ZAG ZIJ- 2(J2)), 2011
• National Institute of Mental Health, State Implementation of EBP’s II, Special Emphasis Panel, 2005
• National Institute on Alcohol Abuse and Alcoholism, Special Emphasis Panel, 2000
• Member, National Institute of Health, Health Services Organization and Delivery Study Section, 2005-2006, Special Emphasis Panel/Scientific Review Group, 2005, Standing Member, 2008 – 2012
• Community-Level Health Promotion Study Section, 2004
• National Cancer Institute Cost-Effectiveness Analysis Working Group, 2010 - 2012
National Academy of Sciences, Engineering, and Medicine / Institute of Medicine
• Member, Health and Medicine Division Committee, National Academies of Sciences, Engineering, and Medicine, 2017 – present
• Committee Member, Institute of Medicine’s Committee on Accounting for Socioeconomic Status in Medicare Payment Programs, 2015 – present
• Member, Board on Population Health and Public Health Practice, Institute of Medicine, 2013 – present
• Member, Institute of Medicine Committee on Valuing Community-Based, Non-Clinical Prevention Policies and Wellness Strategies, 2011 - 2012
Center for Disease Control and Prevention: Meningococcal Vaccines for Children: 2011 Public & Stakeholder Engagement, 2011
National Advisory Board, RWJF Center for Health Policy, 2014 – present
Panel of Health Advisers, Congressional Budget Office, 2013 – present
EDITORIAL ACTIVITIES
Peer Review Activities
Reviewer, American Economic Journal: Economic Policy, 2018
Reviewer, American Journal of Health Economics, 2015 – present
Reviewer, NEJM, 2012 – present
Reviewer, JAMA, 2008 – present
Reviewer, Annals of Internal Medicine, 2005 – present
Reviewer, Value in Health, 2003 – present
Reviewer, Journal of Health Economics, 2002 – present
Reviewer, Health Affairs, 2001 – preset
Reviewer, Addiction, 2001 – present
Reviewer, Statistics in Medicine, 2000 – present
Reviewer, Medical Decision Making, 2000 – present
Reviewer, Health Services Research, 2000 – present
Reviewer, Medical Care, 1997 – present
Reviewer, Journal of Health Policy and Law, 1997
Reviewer, Health Economics, 1997 – present
Reviewer, Health Services Research and Policy
Editorial Board Membership
Medical Care Research and Review, 2012 - present
Associate Editor, Health Economics, 2012 - present
Health Services Research, 2011 - present
Medical Decision Making, 2008 - 2011
Journal of Gerontology: Social Sciences, 2005 – 2007
Pharmacoeconomics, 2004 – present
HONORS AND AWARDS
Awards
Member, National Academy of Medicine, 2018
Article-of-the-Year, AcademyHealth, 2014
Kaffee Billah Memorial Award, Centers for Disease Control and Prevention, 2013
Samuel Martin Health Evaluation Sciences Research Award, 2005
Phi Beta Kappa, 1988
Leadership Award, University of Michigan, 1988
PUBLICATIONS
Journal Articles (Peer-Reviewed)
1. Diebold FX, Neumark D, Polsky D: Is Job Stability Declining in the U.S. Economy? Industrial and Labor Relations Review 49(2): 348-352, 1996.
2. Polsky D, Glick HA, Willke R, Schulman K: Confidence intervals for cost-effectiveness ratios: a comparison of four methods. Health Economics 6(3): 243-52, May-Jun 1997.
3. Diebold FX, Neumark D, Polsky D: Job Stability in the United States. Journal of Labor Economics 15(2): 206-233, 1997.
4. Escarce J, Polsky D, Wozniak G, Pauly MV, Kletke PR: Health Maintnance Organization Penetration and the Practice Location Choices of New Physicians: A Study of Large Metropolitan Areas in the United States. Medical Care 36(11): 1555-1566, 1998.
5. Glick H, Willke R, Polsky D, Llana T, Alves WM, Kassell N, Schulman K: Economic Analysis of Tirilazad Mesylate for Aneurysmal Subarachnoid Hemorrhage: Economic Evaluation of a Phase III Clinical Trial in Europe and Australia. International Journal of Technology Assessment in Health Care 14(1): 145-160, 1998.
6. Glick HA, Polsky D, Willke RJ, Alves WM, Kassell N, Schulman KA: Comparison of the Use of Medical Resources and Outcomes in the Treatment of Aneurysmal Subarachnoid Hemorrhage between Canada and the United States. Stroke 29: 351-358, 1998.
7. Willke RJ, Glick HA, Polsky D, Schulman K: Estimating Country-Specific Cost-effectiveness from Multinational Clinical Trials. Health Economics 7(6): 481-493, 1998.
8. Willke RJ, Glick HA, Polsky D, Schulman K: Estimating Country-Specific Cost-effectiveness from Multinational Clinical Trials. Health Economics 7(6): 481-493, 1998.
9. Neumark D, Polsky D, Hanson D: Has Job Stability Declined Yet? New Evidence for the 1990's. Journal of Labor Economics 17(4): S29-64, 1999.
10. Polsky D: Changing Consequences of Job Separation in the United States. Industrial and Labor Relations Review 52(4): 565-580, 1999.
11. Shea J, Kletke P, Wozniak G, Polsky D, Escarce J: Self-Reported physician Specialties and the Primary Care Content of Medical Practice: A Study of the AMA Physician Masterfile. Medical Care 37(4): 333-338, 1999.
12. Polsky D, Kletke PR, Wozniak GD, Escarce JJ: HMO Penetration and the Geographic Mobility of Practicing Physicians. Journal of Health Economics 19(5): 793-809, Sep 2000.
13. Escarce J, Polsky D, Kletke P, Wozniak G: HMO Growth and the Geographical Redistribution of Generalist and Specialist Physicians, 1987-1997. Health Services Research 35(4): 825-848, 2000.
14. Kletke PR, Polsky D, Wozniak GD, Escarce JE: The Effect of HMO Penetration on Physician Retirement. Health Services Research 35(5): Part III: 17-31, 2000 Notes: online edition: .
15. Glick HA, Briggs AH, Polsky D: Cost-Effectiveness of Health Care Interventions: a Guide to Quantifying Stochastic Uncertainty and Presenting the Results of Cost-Effectiveness Analyses. Expert Reviews in PharmacoEconomics and Outcomes Research 1(1): 25-36, 2001.
16. Polsky D, Bundorf MK, Glick HA, Scalzi C, Kinosian BP: Is the Nurse Responsible for Resource Use in Home Health Care? Journal of Clinical Outcomes Management 8(12): 29-35, 2001.
17. Polsky D, Weinfurt K, Kaplan B, Kim J, Fastenau J, Schulman KA: An Economic and Quality of Life Assessment of Basiliximab Versus Antithymocyte Globulin Immunoprophylaxis in Renal Transplantation. Nephrology Dialysis and Transplantation 16: 1028-1033, 2001.
18. Polsky D, Willke RJ, Scott K, Schulman KA, Glick HA: A Comparison of Scoring Weights for the EuroQol Derived from Patients and the General Public. Health Economics 10: 27-37, 2001.
19. Polsky D, Kletke PR, Wozniak GD, Escarce, JJ: Initial Practice Locations of International Medical Graduates. Health Services Research 37(4): 907-28, Aug 2002.
20. Pauly MV, Nicholson N, Xu J, Polsky D, Danzon PM, Murray JF, Berger JL: A General Model of the Impact of Absenteeism of Employers and Employees. Health Economics 11: 221-231, 2002.
21. Polsky D, Keating N, Weeks JC, Schulman KS: Patient Choice of Breast Cancer Treatment: Impact on Health State Preferences. Medical Care 40(11): 1068-1079, 2002.
22. Polsky D, Onesirosan P, Bauer M, Glick HA: Duration of Therapy and Health Care Costs of Fluoxetine, Paroxetine, and Sertraline in Six Health Plans. Journal of Clinical Psychiatry 63: 156-164, 2002.
23. Glick HA, Orzol SM, Tooley JF, Polsky D, Mauskopf JO: Design and Analysis of Unit Cost Estimation Studies: How Many Types of Hospitalization? How Many Countries? Health Economics 12(7): 517-527, 2003.
24. Hadley J, Polsky D, Mandelblatt JS, Mitchell JM, Weeks JC, Wang Q, Hwang Y: An Instrumental Variable Analysis of the Outcomes of Localized Breast Cancer Treatments in a Medicare Population. Health Economics 12: 171-186, 2003.
25. Hilton ME, Fleming M, Glick H, Gutman MA, Lu Y, McKay J, McLellan AT, Manning W, Meadows J, Mertens JR, Moore C, Mullahy J, Mundt M, Parthasarathy S, Polsky D, Ray GT, Sterling S, Weisner C: Services Integration and Cost Effectiveness. Alcoholism: Clinical and Experimental Research 27(2): 271-280, 2003.
26. Long JA, Polsky D, Asch DA: Receipt of Health Services by Low-Income Veterans. Journal of Health Care for the Poor and Underserved 14(3): 305-317, 2003.
27. Polsky D, Mandelblatt JS, Weeks JC, Venditti L, Hwang Y, Glick HA, Hadley J, Schulman KA: An Economic Evaluation of Breast Cancer Treatment: Considering the Value of Patient Choice. Journal of Clinical Oncology 21(6): 1139-1146, 2003.
28. Rajamohanan KP, Williams SV, Glick HA, Polsky D, Berlin JA, Lowe RA: Factors Affecting Decision to Seek Treatment for Sick Children in Kerala, India. Social Science and Medicine 57(5): 783-790, 2003.
29. Polsky D, Werner RM: The Future of Child Neurology: A Profile of Child Neurology Residents. Journal of Child Neurology vol. 19: 6-13. Jan 2004.
30. Kelz RR, Gimotty PA, Polsky D, Norman S, Fraker D, DeMichele A: Morbidity and Mortality of Colorectal Carcinoma Surgery Differs by Insurance Status. Cancer 101(10): 2187-2194, Nov 15 2004.
31. McGuire KJ, Bernstein J, Polsky D, Silber JH: The 2004 Marshall Urist award: delays until surgery after hip fracture increases mortality. Clinical Orthopedics & Related Research (428): 294-301, Nov 2004.
32. Gurmankin AD, Polsky D, Volpp KG: Accounting for Apparent "Reverse" Racial Disparities in Department of Veterans Affairs (VA)-Based Medical Care: Influence of out-of-VA Care. American Journal of Public Health 94(12): 2076-2078, Dec 2004.
33. Nicholson S, Bundorf K, Stein RM, Polsky D: The Magnitude and Nature of Risk Selection in Employer-Sponsored Health Plans. Health Services Research 39(6 Pt 1): 1817-1838, Dec 2004.
34. Polsky D, Nicholson N: Why are Managed Care Plans Less Expensive: Risk Selection, Utilization, or Reimbursement? Journal of Risk and Insurance 71(1): 21-40, 2004.
35. Werner RM, Polsky D: Strategies to Attract Medical Students to the Specialty of Child Neurology. Pediatric Neurology 30: 35-38, 2004.
36. Werner RM, Polsky D: Comparing the Supply of Pediatric Subspecialists and Child Neurologists. Journal of Pediatrics 146(1): 20-25, Jan 2005.
37. Werner RM, Asch DA, Polsky D: Racial Profiling: The Unintended Consequences of Coronary Artery Bypass Graft Report Cards. Circulation 111(10): 1257-1263, Mar 15 2005.
38. Metlay JP, Cohen A, Polsky D, Kimmel SE, Koppel R, Hennessy S: Medication Safety in Older Adults: Home-based Practice Patterns. Journal of the American Geriatrics Society 53(6): 976-82, Jun 2005.
39. Polsky D, Doshi JA, Marcus S, Oslin D, Rothbard A, Thomas N, Thompson CL: Long-Term Risk for Depressive Symptoms After a Medical Diagnosis. Archives of Internal Medicine 165(11): 1260-1266, Jun 13 2005.
40. Polsky D, Stein R, Nicholson S, Bundorf MK: Employer Health Insurance Offerings and Employee Enrollment Decisions. Health Services Research 40(5 Pt 1): 1259-1278, Oct 2005.
41. Long JA, Polsky D, Metlay JP: Changes Patterns of Out-Patient Care by Veterans. American Journal of Public Health 95(12): 2246-2251, Dec 2005.
42. Nicholson S, Pauly MV, Polsky D, Baase CM, Billotti GM, Ozminkowski RJ, Berger ML, Sharda CE: How to Present the Business Case for Healthcare Quality to Employers. Applied Health Economics and Health Policy 4(4): 209-218, 2005.
43. Polsky D, Weiner J, Bale JF, Ashwal S, Painter MJ: Specialty Care by Child Neurologists: A Workforce Analysis. Neurology 64: 942-948, 2005.
44. Ross SJ, Polsky D, Sochalski J: Nursing Shortages and International Nurse Migration. International Nursing Review 52(4): 253-262, Dec 2005.
45. Pagan JA, Ross S, Yau J, Polsky D: Self-Medication and Health Insurance Coverage in Mexico. Health Policy 75(2): 170-177, Jan 2006.
46. Nicholson S, Pauly MV, Polsky D, Sharda C, Szrek H, Berger ML: Measuring the Effects of Workloss on Productivity with Team Production. Health Economics 15: 111-123, Feb 2006.
47. Doshi J, Glick H, Polsky D: Analyses of Cost Data in Economic Evaluations Conducted Alongside Randomized Controlled Trials. Value in Health 9(5): 334-340, 2006.
48. Odibo AO, Stamilio DM, Macones GA, Polsky D: 17 Alpha-Hydroxyprogesterone Caproate for the Prevention of Preterm Delivery: A Cost-Effectiveness Analysis: Obstetrics and Gynecology 108(3 Pt 1), 2006.
49. Polsky D, Armstrong KA, Randall TC, Ross RN, Even-Shoshan O, Rosenbaum PR, Silber JH: Variation in Chemotherapy Utilization in Ovarian Cancer: The Relative Contribution of Geography. Health Services Research 41(6): 2201-2218, Dec 2006.
50. Polsky D, Doshi JA, Bauer MS, Glick HA: Clinical Trial-based Cost-Effectiveness Analyses of Antipsychotic use. American Journal of Psychiatry 163(12): 2047-2056, Dec 2006.
51. Ross SJ, Pagán JA, Polsky D: Access to Health Care for Migrants Returning to Mexico. Journal of Health Care for the Poor and Underserved 17(2): 374-385, 2006.
52. Polsky D, Lave J, Klusaritz H, Jha A, Pauly MV, Cen L, Xie H, Stone R, Chen H, Volpp KG: Is Lower 30-day Mortality Post-hospital Admission Among Blacks Unique to the Veterans Affairs Health Care System? Medical Care 45(11): 1083-1089, November 2007.
53. Doshi J, Polsky D: Generosity of Drug Benefits and Essential Medication Use among Medicare Beneficiaries with Retiree Health Insurance. American Journal of Managed Care 13: 425-431, 2007.
54. Doshi JA, Polsky D, Chang VW: Prevalence and Trends in Obesity Among Aged and Disabled U.S. Medicare Beneficiaries, 1997-2002. Health Affairs 26(4): 1111-1117, 2007.
55. Polsky D, Ross SJ, Brush BL, Sochalski J: Foreign-trained nurses: 10-year trends in skills and country of origin. American Journal of Public Health 97(5): 895-899, 2007.
56. Silber JH, Rosenbaum PR, Polsky D, Ross RN, Even-Shoshan O, Schwartz JS, Armstrong KA, Randall TC: Does ovarian cancer treatment and survival differ by the specialty providing chemotherapy? Journal of Clinical Oncology 25(10): 1169-1175, 2007.
57. Volpp KG, Stone R, Jha A, Lave J, Pauly MV, Klusaritz H, Chen H, Cen L, Brucker N, Polsky D: Is 30-day Hospital Mortality Really Lower for Black Veterans Compared to White Veterans? Health Services Research. 42(2): 1613-1631, 2007.
58. Doshi J, Cen L, Polsky D: Depression and Retirement in Late Middle Aged U.S. Workers. Health Services Research 43(2), April 2008.
59. Pauly MV, Nicholson S, Polsky D, Berger ML, Sharda C: Valuing Reductions in On-the-Job Illness: "Presenteeism" from Managerial and Economic Perspectives. Health Economics 17(4): 469-485, April 2008.
60. Mallya G, Pollack C, Polsky D: Are Primary Care Physicians Ready to Practice in a Consumer-Driven Environment? American Journal of Managed Care 14(10): 661-668, 2008.
61. Mandell DS, Morales KH, Marcus SC, Stahmer AC, Doshi J, Polsky D: Psychotropic Medication use Among Medicaid-Enrolled Children with Autism Spectrum Disorders. Pediatrics 121: e441-448, 2008.
62. Pollack C, Mallya G, Polsky D: The Impact of Consumer-Directed Health Plans and Patient Socioeconomic Status on Physician Recommendations for Colorectal Cancer Screening. Journal of General Internal Medicine 23(10): 1595-1601, 2008.
63. Polsky D, Jha AK, Lave J, Pauly MV, Cen L, Klusaritz H, Chen Z, Volpp KG: Short and Long-term Mortality after an Acute Illness for Elderly Whites and Blacks. Health Services Research 43(4): 1388-1402, 2008.
64. Polsky D, Doshi JA, Escarce J, Manning W, Paddock SM, Cen L, Rogowski J: The Health Effects of Medicare for the Near-Elderly Uninsured. Health Services Research 44(3): 926-945, 2009.
65. Polsky D, Eremina D, Hess G, Hill J, Hulnick S, Roumm A, Whyte JL, Kallich J: The Importance of Clinical Variables in Comparative Analyses Using Propensity Score Matching: The Case of ESA Costs for the Treatment for Chemotherapy Induced Anemia. PharmacoEconomics 27(9): 755-765, 2009.
66. Polsky D, Glick H: Costing in Randomised Trials: Caveat Emptor. PharmacoEconomics 27(3): 179-188, 2009.
67. Polsky D, Grande D: The Burden of Health Care Costs for Working Families - Implications for Reform. New England Journal of Medicine 361(5): 437-439, 2009.
68. Werner RM, Konetzka RT, Stuart EA, Norton EC, Polsky D, Park J: Impact of Public Reporting on Quality of Postacute Care. Health Services Research 44(4): 1169-1187, 2009.
69. Mandell DS, Morales KH, Xie M, Polsky D, Stahmer A, Marcus SC: County-Level Variation in the Prevalence of Medicaid-Enrolled Children with Autism Spectrum Disorders. Journal of Autism and Developmental Disorders 40(10): 1241-1246, 2010.
70. Polsky D, Doshi JA, Escarce J, Manning W, Paddock SM, Cen L, Rogowski J: Response to McWilliams Commentary: "Assessing the Health Effects of Medicare Coverage for Previously Uninsured Adults: A Matter of Life and Death? Health Services Research 45(5): 1423-1428, 2010.
71. Polsky D, Glick HA, Yang J, Subramaniam GA, Poole SA, Woody GE: Cost-effectiveness of Extended Buprenorphine-Naloxone Treatment for Opioid-Addicted Youth: Data from a Randomized Trial. Addiction 105: 1616-1624, 2010.
72. Polsky D, Marcus SC, Werner R: Malpractice Premiums and the Supply of Obstetricians. Inquiry 47: 48-61, 2010.
73. Werner RM, Stuart EA, Polsky D: What Drives Nursing Home Quality Improvement Under Public Reporting? An Examination of Post-Accute Care. Health Affairs 29(9): 1706-1713, 2010.
74. Apter AJ, Wang X, Bogen DK, Rand CS, McElligott S, Polsky D, Gonzalez R, Priolo C, Adam B, Geer S, Ten Have T: Problem-solving to Improve Adherence and Asthma Outcomes in Urban Adults with Moderate or Severe Asthma: a Randomized Controlled Trial. The Journal of Allergy and Clinical Immunology 128(3): 516-523, 2011.
75. Armstrong K, Randall TC, Polsky D, Moye E, Silber JH: Racial Differences in Surgeons and Hospitals for Endometrial Cancer Treatment. Medical Care 49(2): 207-214, 2011.
76. Basu A, Polsky D, Manning WG: Estimating Treatment Effects on Healthcare Costs Under Exogeneity: Is There a 'Magic Bullet'? Health Services and Outcomes Research Methodology 11(1-2): 1-26, 2011.
77. Epstein AJ, Polsky D, Yang F, Yang L, Groeneveld PW: Coronary Revascularization Trends in the United States: 2001-2008. JAMA 305(17): 1769-1776, 2011.
78. Groeneveld PW, Epstein AJ, Yang F, Yang L, Polsky D: Medicare's policy on carotid stents limited use to hospitals meeting quality guidelines yet did not hurt disadvantaged. Health Affairs 30(2): 312-321, 2011.
79. Groeneveld PW, Polsky D, Yang F, Yang L, Epstein A: The impact of new cardiovascular device technology on health care costs. Archives of Internal Medicine 171(14): 1289-1291, 2011.
80. Meisel ZF, Pines JM, Polsky D, Metlay JP, Neuman MD, Branas CC: Variations in Ambulance Use in the United States: The Role of Health Insurance. Academic Emergency Medicine 18: 1035-1044, 2011.
81. Werner RM, Kolstad J, Stuart EA, Polsky D: The Effect of Pay-for-Performance in Hospitals: Lessons for Quality Improvement. Health Affairs 30(4): 690-698, 2011.
82. Werner RM, Konetska T, Stuart EA, Polsky D: Changes in patient sorting to nursing homes under public reporting: Improved patient matching or provider gaming? Health Services Research 46(2): 555-571, 2011.
83. Baiocchi M, Small D, Polsky D, Yang L, Groeneveld P: Near/Far Matching - A Study Design Approach to Instrumental Variables. Health Services and Outcomes Research Methodology 12: 237-253, 2012.
84. Bisgaier J, Polsky D, Rhodes KV: Academic Medical Centers and Equity in Specialty Care Access for Children. Archives of Pediatrics & Adolescent Medicine 166(4): 304-310, 2012.
85. Bonafede M, Suaya JA, Wilson K, Mannino DM, Polsky D: U.S. Incidence and Excess Cost of Community-Acquired Pneumonia in a Large Commercially-Insured Working-Age Population. American Journal of Managed Care 18(7): 380-387, 2012.
86. Campbell ANC, Nunes EV, Miele GM, Matthews A, Polsky D, Ghitza U, Turrigiano E, Bailey GL, Van Veldhuisen P, Chapdelaine R, Froias A, Stitzer ML, Carroll KM, Winhusen T, Clingerman S, Perez L, McClure W, Goldman B, Crowell AR : Methodological issues in the design of an effectiveness trial for a computer-assisted intervention: An example from the Clinical Trials Network. Contemporary Clinical Trials 33: 386-395, 2012.
87. Decker SL, Doshi JA, Knaup AE, Polsky D: Health Service Use Among the Previously Uninsured: Is Subsidized Health Insurance Enough? Health Economics 21(10): 1155-1168, 2012.
88. Epstein AJ, Polsky D, Yang L, Yang F, Groeneveld PW: Geographic Variation in Implantable Cardioverter-Defibrillator Use and Heart Failure Survival. Medical Care 50(1): 10-17, 2012.
89. Gupta N, Polsky D: High Deductible Health Plans: Does Cost Sharing Stimulate Increased Consumer Sophistication? Health Expectations 18(3): 335-343, December 2012.
90. Konetzka T, Werner R, Polsky D: Shipping Out Instead of Shaping Up: Rehospitalization from Nursing Homes as an Unintended Effect of Public Reporting. Journal of Health Economics 32(2): 341-352, 2012.
91. Kruse GB, Polsky D, Stuart EA, Werner RM: The Effect of Pay-for-Performance on Hospital and Medicare Costs. Health Services Research 47(6): 2118-2136, 2012.
92. Polsky D, Bonafede M, Suaya JA: Comorbidities as a Driver of the Excess Costs of Community-Acquired Pneumonia in U.S. Commercially-Insured Working age Adults. BMC Health Services Research 12(1): 379, 2012.
93. Reed SD, Li Y, Kamble S, Polsky D, Graham FL, Bowers MT, Samsa GP, Paul S, Shulman KA, Whellan DJ, Riegel BJ: Introduction of the Tools for Economic Analysis of Patient Management Interventions in Heart Failure Costing Tool: A User-Friendly Spreadsheet Program to Estimate Costs of Providing Patient-Centered Interventions. Circulation: Cardiovascular Quality and Outcomes 5: 113-119, 2012.
94. Schackman BR, Leff JA, Polsky D, Moore BA, Fiellin DA: Cost-Effectiveness of Long-Term Outpatient Buprenorphine-Naloxone Treatment for Opioid Dependence in Primary Care. Journal of General Internal Medicine 27(6): 669-676, 2012.
95. Thomas C, Marian R, Chapman J, Stason W, Tomkins C, Suaya J, Polsky D, Mannino D, Shepard D: Cost of Pneumonia in Medicare Beneficiaries. Chest 142(4): 973-981, 2012.
96. Werner RM, Norton EC, Konetzka RT, Polsky D: Do Consumers Respond to Publicly Reported Quality Information? Evidence from Nursing Homes. Journal of Health Economics 31: 50-61, 2012.
97. Kullgren JT, Volpp KG, Polsky D: Are the Healthy Behaviors of US High-Deductible Health Plan Enrollees Driven by People who Chose These Plans? Smoking as a Case Study. PLOS ONE 8(2), February 2013.
98. Jung K, Polsky, D: Competition and Quality in Home Health Care Markets. Health Economics May 2013.
99. Bekelman JE, Handorf EA, Guzzo T, Pollack CE, Christodouleas J, Resnick MJ. Swisher McClure S, Vaughn D, Ten Have T, Polsky D, Mitra N: Radical Cystectomy Versus Bladder Preserving Therapy for Muscle-Invasive Urothelial Carcinoma: Examining Confounding and Misclassification Bias in Cancer Observational Comparative Effectiveness Research. Value in Health 16(4): 610-618, June 2013.
100. Epstein AJ, Groeneveld P, Harhay MO, Yang F, Polsky D: The Impact of Minimally Invasive Surgical Technology on Medial Expenditures and Employee Absenteeism. JAMA Surgery 148(7): 641-647, July 2013.
101. Werner RM, Konetska T, Polsky D: The Effect of Pay-for-Performance in Nursing Homes. Health Services Research 48(4): 1393-1414, August 2013.
102. Virudachalam S, Long JA, Harhay MO, Polsky DE, Feudtner C: Prevalence and Patterns of Cooking Dinner at Home in the United States, 2007-2008. Public Health Nutrition Page: 1-9, Oct 2013.
103. David G, Rawley E, Polsky D: Integration and Task Allocation: Evidence from Patient Care. Journal of Economics & Management Strategy 22(3): 617-639, 2013.
104. Anderson BR, McElligott S, Polsky D, Vetter VL: Electrocardiographic Screening for Hypertrophic Cardiomyopathy and Long QT Syndrome: The Drivers of Cost-Effectiveness for the Prevention of Sudden Cardiac Death. Pediatric Cardiology 35(2), Feb 2014.
105. Polsky D, David G, Yang J, Kinosian B, Werner R: The Effect of Entry Regulation in the Health Care Sector: The Case of Home Health. Journal of Public Economics 110: 1, February 2014.
106. Campbell AN, Nunes EV, Matthews AG, Stitzer M, Miele GM, Polsky D, Turrigiano E, Walters S, McClure EA, Kyle TL, Wahle A, Van Veldhuisen P, Goldman B, Babcock D, Stabile PQ, Winhusen T, Ghitza UE: Internet-Delivered Treatment for Substance Abuse: A Multisite Randomized Controlled Trial. Am J Psychiatry 171(6): 683-690, June 2014.
107. Rhodes KV, Kenney GM, Friedman AB, Saloner B, Lawson CC, Chearo D, Wissoker D, Polsky D: Primary Care Access for new Patients on the eve of Health Care Reform. JAMA 174(6): 861-869, June 2014.
108. Ryan AM, Polsky D, Press MJ, Bach P: The Zigzagging Zeitgeist of Health Services Research: Rapidly Changing Priorities in the Field. The Journal of Delivery Science and Innovation 2(2), July 2014.
109. Bisgaier J, Rhodes KV, Polsky D: Factors Associated with Increased Specialty Care Access in an Urban Area: The Roles of Local Workforce Capacity and Practice Location Journal of Health Politics, Policy, and Law, September 2014.
110. Richards MR, Saloner B, Kenney G, Rhodes K, Polsky D: Access Points for the Underserved: Primary Care Appointment Availability at Federally Qualified Health Centers in Ten States. Medical Care 52(9): 818-825, September 2014
111. Polsky D, Richards M, Basseyn S, Wissoker D, Kenney GM, Zuckerman S, Rhodes KV: Appointment Availability after Increases in Medicaid Payments for Primary Care. New England Journal of Medicine 372(6): 537-545, February 2015.
112. Wong C, Bain A, Antwi Y, Merchant R, Slap G, Polsky D, Ford C: Inpatient Hospitalizations Among Insured Young Adults, 2012-2013, United States: Journal of Adolescent Health 56(2): S46, February 2015
113. Bekelman JE, Mitra N, Handorf EA, Uzzo RG, Hahn SA, Polsky D, Armstrong K: Effectiveness of Androgen Deprivation Therapy and Radiotherapy for Older Men with Locally Advanced Prostate Cancer. Journal of Clinical Oncology 33(7): 716, March 2015.
114. Saloner B, Rhodes KV, Kenney G, Friedman A, Polsky D: Primary Care Appointment Availability and Preventive Care Utilization: Evidence from an Audit Study. Medical Care Research and Review 72(2): 149-167, April 2015.
115. Glick HA, McElligott S, Pauly MV, Willke RJ, Bergquist H, Doshi J, Fleisher LA, Kinosian B, Perfetto E, Polsky D, Schwartz, SJ: Comparative Effectiveness and Cost-Effectiveness Analyses Frequently Agree on Value. Health Affairs 34(5): 805-811, May 2015.
116. Saloner B, Polsky D, Kenney GM, Hempstead K, Rhodes KV: Most Uninsured Adults Could Schedule Primary Care Appointments Before The ACA, But Average Price Was $160. Health Affairs 34(5): 773-780, May 2015.
117. Lee DC, Smith SW, Carr BG, Goldfrank LR, Polsky D: Redistribution of Emergency Department Patients After Disaster-Related Closures of a Public Versus Private Hospital in New York City. Disaster Medicine and Public Health Preparedness 9(3): 256-264, June 2015.
118. Becker NV, Polsky D: Women Saw Large Decrease in Out-Of-Pocket Spending for Contraceptives After ACA Mandate Removed Cost Sharing. Health Affairs (34), 1204-1211, July 2015.
119. Mehta SJ, Polsky D, Zhu J, Lewis JD, Kolstad JT, Loewenstein G, Volpp KG: ACA-Mandated Elimination of Cost Sharing for Preventive Screening has had Limited Early Impact. The American Journal of Managed Care 21(7): 511-517, July 2015.
120. Wong C, Nirenburg G, Polsky D, Town R, Baker T: Insurance Plan Presentation and Decision Support on and State-Based Web Sites Created for the Affordable Care Act. Annals of Internal Medicine 163(4): 327-328, August 2015.
121. Aysola J, Rhodes KV, Polsky D: Patient-Centered Medical Homes and Access to Services for New Primary Care Patients. Medical Care 53(10): 857-862, October 2015.
122. Reed SD, Neilson MP, Gardner M, Li Y, Briggs AH, Polsky DE, Graham FL, Bowers MT, Paul SC, Granger BB, Schulman KA, Whellan DJ, Riegel BJ, Levy WC: TEAM-HF Cost-Effectiveness Model: A Web-Based Program Designed to Evaluate the Cost-Effectiveness of Disease Management Programs in Heart Failure. American Heart Journal 170(5): 951-960, November 2015.
123. Horowitz J, Polsky D: Cross Border Effects of State Health Technology Regulation. American Journal of Health Economics 1(1): 101-123, Winter 2015.
124. Jung JK, Wu B, Kim H, Polsky D: The Effect of Publicized Quality Information on Home Health Agency Choice. Medical Care Research and Review 73(6):703-723, December 2015.
125. Lee DC, Carr BG, Smith TE, Tran VC, Polsky D, Branas CC: The Impact of Hospital Closures and Hospital and Population Characteristics on Increasing Emergency Department Volume: A Geographic Analysis Population Health Management, December 2015.
126. Murphy SM, Campbell AN, Ghitza UE, Kyle TL, Bailey GL, Nunes EV, Polsky D: Cost-Effectiveness of an Internet-Delivered Treatment for Substance Abuse: Data from a Multisite Randomized Controlled Trial. Drug and Alcohol Dependence 161: 119-126, April 2016.
127. Richards M, Polsky D: Influence of Provider mix and Regulation on Primary Care Services Supplied to US Patients. Health Economics, Policy and Law 11(2): 193-213, April 2016.
128. Richards MR, Saloner B, Kenney GM, Rhodes KV, Polsky D: Availability of New Medicaid Patient Appointments and Role of Rural Health Clinics. Health Services Research 51(2): 570-591, April 2016.
129. Wong CA, Polsky D, Jones AT, Weiner J, Town RJ, Baker T: For Third Enrollment Period, Marketplaces Expand Decision Support Tools to Assist Consumers. Health Affairs 35(4): 680-687, April 2016.
130. Basu A, Axelsen K, Grabowski DC, Meltzer DO. Polsky D, Ridley DB, Wiederkehr D, Philipson TJ: Real World Data: Policy Issues Regarding Their Access and Use. Medical Care, May 2016.
131. Grande D, Rhodes K, Zuo J, Venkat R, Polsky D: A Mystery Shopper Study of Primary Care Access Following the Medicaid Expansion in a Large Urban Area. Journal of General Internal Medicine 31: S101, May 2016.
132. Seymour J, Polsky D, Brown E, Grande D: Spatial Access to Primary Care-The Contribution of Community Health Centers to Addressing Access Disparities in a Large Urban Area. Journal of General Internal Medicine 31: S400, May 2016.
133. Lee DC, Kelly DM, Polsky D, Corodova E, Carr BG: Geographic variation in the demand for emergency care: A local population-level analysis. Healthcare 4(2): 98-103, June 2016.
134. Werner RM, Konetzka RT, Polsky D: Changes in Consumer Demand Following Public Reporting of Summary Quality Ratings: An Evaluation in Nursing Homes. Health Services Research 2: 1291-1309, June 2016.
135. Bain A, Wong CA, Slap G, Polsky D, Merchant RM, Akosa Antwi Y, Rubin D, Ford CA: Common and Costly Hospitalizations among Insured Young Adults since the Affordable Care Act. Journal of Adolescent Health 59(1): 61-67, July 2016.
136. Brown EJ, Polsky D, Barbu CM, Seymour JW, Grande D: Racial Disparities in Geographic Access to Primary Care in Philadelphia. Health Affairs 35(8): 1374-1381, August 2016.
137. Yasaitis LC, Pajerowski W, Polsky D, Werner RM: Physicians' Participation in ACOs Is Lower in Places with Vulnerable Populations than in More Affluent Communities. Health Affairs 35(8): 1382-1390, August 2016.
138. Basseyn S, Saloner B, Kenney GM, Wissoker D, Polsky D, Rhodes KV: Primary Care Appointment Availability for Medicaid Patients: Comparing Traditional and Premium Assistance Plans. Med Care 54(9): 878-883, September 2016.
139. Murphy SM, Polsky D: Economic Evaluations of Opioid Use Disorder Interventions: A Systematic Review. PharmacoEconomics 34(9): 863-887, September 2016.
140. Polsky D, Cidav C, Swanson A: Marketplace Plans with Narrow Physician Networks Feature Lower Monthly Premiums than Plans with Larger Networks. Health Affairs 35(10): 1842-1848, October 2016.
141. Branas CC, Kondo MC, Murphy SM, South EC, Polsky D, MacDonald JM: Urban Blight Remediation as a Cost-Beneficial Solution to Firearm Violence. Forthcoming in American Journal of Public Health 106(12): 2158-2164, December 2016.
142. Basu A, Axelsen K, Grabowski D, Meltzer D, Polsky D, Ridley D, Wiederkehr D, Philipson T: Real-World Data. Medical Care (54)12: 1038-1044, Author Reply 1048-1049, December 2016.
143. Wong C, Bain A, Polsky D, Merchant R, Antwi Y, Slap G, Rubin D, Ford C: The Use and Out-of-Pocket Cost of Urgent Care Clinics and Retail-Based Clinics by Adolescents and Young Adults Compared with Children. Journal of Adolescent Health 60(1): 107-112, January 2017.
144. Saloner B, Cope L, Hempstead K, Rhodes K, Polsky D, Kenny G: Price Transparency in Primary Care: Can Patients Learn About Costs When Scheduling an Appointment? Journal of General Internal Medicine 32(7): 815-821, February 2017.
145. Schwamm L, Chumbler N, Brown E, Fonarow G, Berube G, Nystrom K, Suter R, Zavala M, Polsky D, Radhakrishnan K, Lacktman N, Horton K, Malcarney MB, Halamka J, Tiner AC: Recommendations for the Implementation of Telehealth in Cardiovascular and Stroke Care: A Policy Statement from the American Heart Association Circulation 135(7): e24-e44, February 2017.
146. Bond A, Pajerowski W, Polsky D, Richards MR: Market Environment and Medicaid Acceptance: What Influences the Access Gap? Health Economics 26(12): 1759-1766, March 2017.
147. Rhodes K, Basseyn S, Friedman A, Kenney G, Wissoker D, Polsky D: Access to Primary Care Appointments Following 2014 Insurance Expansions. Annals of Family Medicine 15(2): 107-112, March 2017.
148. Seymour J, Polsky D, Brown E, Barbu C, Grande D: The Role of Community Health Centers in Reducing Disparities in Spatial Access to Primary Care. Journal of Primary Care & Community Health 8(3): 147-152, March 2017.
149. Polsky D, Candon M, Saloner B: Changes in Primary Care Access Between 2012 and 2016 for New Patients with Medicaid and Private Coverage. JAMA Internal Medicine 177(4): 588-590, April 2017.
150. Wong C, Kan K, Cidav Z, Nathenson R, Polsky D: Pediatric and Adult Physician Networks in Affordable Care Act Marketplace Plans. Pediatrics 139(4): e20133117, April 2017.
151. Murphy SM, Polsky D, Lee JD, Friedmann PD, Kinlock TW, Nunes EV, Bonnie RJ, Gordon M, Chen DT, Boney TY, O'Brien CP: Cost-Effectiveness of Extended Release Naltrexone to Prevent Relapse Among Criminal Justice-Involved Individuals with a History of Opioid use Disorder. Addiction 112(8): 1440-1450, August 2017.
152. Yasaitis L, Bekelman J, Polsky D: Relation Between Narrow Networks and Providers of Cancer Care. Journal of Clinical Oncology 35(27): 3131-3135, September 2017.
153. Zhu J, Zhang Y, Polsky D: Networks in ACA Marketplaces Are Narrower for Mental Health Care Than for Primary Care. Health Affairs 36(9): 1624-1631, September 2017.
154. Zhu J, Zhang Y, Wu B, Polsky D: Association Between Number of Insurers and Premium Rates in the Affordable Care Act Marketplace. JAMA Internal Medicine September 177(11): 1684-1686, November 2017.
155. Ryskina KL, Polsky D, Werner RM: Physicians and Advance Practitioners Specializing in Nursing Home Care, 2012-2015. JAMA 318(20): 2040-2042, November 2017.
156. Candon M, Zuckerman S, Wissoker D, Saloner B, Kenney G, Rhodes K, Polsky D: Declining Medicaid Fees and Primary Care Appointment Availability for New Medicaid Patients. JAMA Internal Medicine 178(1): 145-146, January 2018.
157. McKay JR, Gustafson DH, Ivey M, McTavish F, Pe-Romashko K, Curtis B, Oslin DA, Polsky D, Quanbeck A, Lynch KG: Effects of Automated Smartphone Mobile Recovery Support and Telephone Continuing Care in the Treatment of Alcohol use Disorder: Study Protocol for a Randomized Controlled Trial. Trials 19(1): 82, January 2018.
158. Bachhuber M, Saloner B, LaRochelle M, Merlin J, Maughan B, Polsky D, Shaparin N, and Murphy S: Physician Time Burden Associate with Querying Prescription Drug Monitoring Programs. American Academy of Pain Medicine 19(10):1952-1960, March 2018.
159. Navathe A, Liao J, Dykstra S, Wang E, Lyon Z, Wu R, Polsky D, Emanuel E: Volume Responses and Patient Selection in Voluntary Bundled Payment. Journal of General Internal Medicine 33: S391, April 2018.
160. Graves R, Tufts C, Meisel Z, Polsky D, Ungar D, Merchant R: Opioid Discussion in the Twittersphere. Substance Use and Misuse 53(13): 2132-2139, April 2018.
161. Ryskina K, Yuan Y, Polsky D, Werner R: Hospitalist vs. Non-Hospitalist Care Outcomes and Costs for Patients Discharged to Post-Acute Care in Skilled Nursing Facilities (SNFS). Journal of General Internal Medicine 33: S217-S217, April 2018.
162. Saloner B, Hempstead K, Rhodes K, Polsky D, Pan C, Kenney G: Most Primary Care Physicians Provide Appointments, but Affordability Remains a Barrier for the Uninsured. Health Affairs37(4): 624-634, April 2018.
163. Wong CA, Kulhari S, McGeoch EJ, Jones AT, Weiner J, Polsky D, Baker T: Shopping on the Public and Private Health Insurance Marketplaces: Consumer Decision Aids and Plan Presentation. Journal of General Internal Medicine 33(8): 1400-1410, May 2018.
164. Navathe A, Liao J, Polsky D, Shah Y, Huang Q, Zhu J, Lyon Z, Wang R, Rolnick J, Martinez J, Emanuel E: Comparison of Hospitals Participating in Medicare's Voluntary and Mandatory Orthopedic Bundle Programs. Health Affairs 37(6): 854-863, June 2018.
165. Tufts C, Polsky D, Volpp K, Groeneveld P, Ungar L, Merchant R, Pelullo AP: Characterizing Tweet Volume and Content About Common Health Conditions Across Pennsylvania. JMIR Public Health and Surveillance 4(4): e10834, June 2018.
166. Polsky D, Candon M, Chatterjee P, Chen X: Scope of Primary Care Physicians' Participation in The Health Insurance Marketplaces. Health Affairs 37(8): 1252-1256, August 2018.
167. Navathe A, Liao J, Shah Y, Lyon Z, Chatterjee P, Polsky D, Emanuel E: Characteristics of Hospitals Earning Savings in the First Year of Mandatory Bundled Payment for Hip and Knee Surgery. JAMA 319(9): 930-932, March 2018.
168. Candon M, Rhodes K, Polsky D: Acuity-based Scheduling in Primary Care. Medical Care 56(10): 818-821, October 2018.
169. Delgado MK, Huang Y, Meisel Z, Hennessy S, Yokell M, Polsky D, Perrone J: National Variation in Opioid Prescribing and Risk of Prolonged Use for Opioid-Naive Patients Treated in the Emergency Department for Ankle Sprains. Annals of Emergency Medicine, 72(4): 389-400.e1, October 2018.
170. Miclette M, Leff J, Cuan I, Samet J, Saloner B, Mendell G, Bao Y, Ashburn M, Bachhuber M, Schackman B, Polsky D, Meisel Z: Closing the Gaps in Opioid use Disorder Research, Policy and Practice: Conference Proceedings. Addiction Science and Clinical Practice 13(1): 22, November 2018.
171. Kennedy GT, Ukert BD, Predina JD, Newton AD, Kucharczuk JC, Polsky D: Implications of Hospital Volume on Costs Following Esophagectomy in the United States. Journal of Gastrointestinal Surgery 22(11): 1845-1854, November 2018.
172. Krutsinger D, McMahon J, Stephens-Shields A, Bayes B, Brooks S, Hitsman B, Lubitz SF, Reyes C, Schnoll R, Greysen R, Mercede A, Patel M, Reale C, Barg F, Karlawish J, Polsky D, Volpp K, Halpern S: Randomized Evaluation of Trial Acceptability by Incentive (RETAIN): Study Protocol for two Embedded Randomized Controlled Trials. Contemporary Clinical Trials 76: 1-8, January 2019.
173. Liao J, Emanuel E, Polsky D, Huang Q, Shah Y, Zhu J, Lyon Z, Dykstra S, Dinh C, Cousins D, Navathe A: National Representativeness of Hospitals and Markets in Medicare’s Mandatory Bundled Payment Program. Health Affairs 38(1): 44-53, January 2019.
174. Wu B, Jung J, Kim H, Polsky D: Entry Regulation and the Effect of Public Reporting: Evidence of Home Health Compare. Health Economics 28(4): 492-516, January 2019.
175. Werner RM, Kanter GP, Polsky D: Association of Physician Group Participation in Accountable Care Organizations with Patient Social and Clinical Characteristics. JAMA Netw Open 2(1): e187220, January 2019.
176. Saloner B, Wilk AS, Wissoker D, Candon M, Hempstead K, Rhodes KV, Polsky D, Kenney GM: Changes in Primary Care Access at Community Health Centers Between 2012/2013 and 2016. Health Services Research 54(1): 181-186, February 2019.
177. Meisel Z, Mitchell J, Polsky D, Boualam N, McGeoch E, Weiner J, Miclette M, Purtle J, Schackman B, Cannuscio C: Strengthening Partnerships between Substance use Researchers and Policy Makers to take Advantage of a Window of Opportunity. Substance Abuse Treatment, Prevention, and Policy 14(1):12, March 2019.
178. Wong C, Ellsworth E, Madanay F, Chandrasekaran D, Moore M, Polsky D, Ubel P: The Roles of Assisters and Automated Decision Support Tools in Consumers’ Marketplace Choices: Room for Improvement. Health Affairs 38(3): 473-481, March 2019.
179. Feyman, Y., Figueroa, J. F., Polsky, D. E., Adelberg, M., & Frakt, A. Primary Care Physician Networks in Medicare Advantage. Health Affairs (Project Hope) 38(4):537-544, April 2019.
180. Adelberg M, Frakt A, Polsky D, Strollo MK: Improving Provider Directory Accuracy: Can Machine-Readable Directories Help? The American Journal of Managed Care 25(5):241-245, May 2019.
181. Drake C, Zhang Y, Chaiyachati KH, Polsky D. The Limitations of Poor Broadband Internet Access for Telemedicine Use in Rural America: An Observational Study. Ann Intern Med, May 2019.
182. Evans CN, Volpp KG, Polsky D, Small DS, Kennedy EH, Karpink K, Djaraher R, Mansi N, Rareside CAL, Patel MS: Prediction using a Randomized Evaluation of Data collection Integrated through Connected Technologies (PREDICT): Design and Rationale of a Randomized Trial of Patients Discharged from the Hospital to Home. Contemporary Clinical Trials 83:53-56, 2019.
Books or Monographs
1. Glick HA, Doshi JA, Sonnad SS, Polsky D: Economic Evaluation in Clinical Trials. Oxford University Press. Oxford University Press, 2007.
Articles, Editorials and other publications non peer reviewed
1. Diebold FX, Neumark D, Polsky D: Job Stability in the United States. National Bureau of Economic Research (NBER) Working Paper (4859), 1994.
2. Neumark D, Polsky D, Hanson D: Has Job Stability Declined Yet? New Evidence for the 1990's. National Bureau of Economic Research (NBER) Working Paper (6330), 1997.
3. Neumark D, Polsky D: Changes in Job Stability and Job Security: Evidence and Anecdotes. Proceedings of the 5oth Annual Meeting of the Industrial Relations Research Association. 1: 78-87, 1998.
4. Glick HA, Polsky D: Analytic Approaches for the Evaluation of Costs. Hepatology 29: 18S-22S, 1999 Notes: Review.
5. Glick H, Polsky D, Schulman KA: Trial-based economic evaluations: an overview of design and analysis. Theory and Practice of Economic Evaluation in Health Care. Drummond M, McGuire A. (eds.). London UK: Oxford University Press Chapter 6: 113-140, 2001.
6. Nicholson S, Bundorf MK, Stein RM, Polsky D: The Magnitude and Nature of Risk Selection in Employer-Sponsored Health Plans. National Bureau of Economic Research (NBER) Working Paper (9937), 2003.
7. Polsky D: More Intensive Treatment of Addiction Does Benefit Society. Addiction 99(1): 130, Jan 2004.
8. Nicholson S, Pauly MV, Polsky D, Sharda C, Szrek, H, Berger M: Measuring the Effects of Workloss on Productivity with Team Production. National Bureau of Economic Research (NBER) Working Paper (10632), 2004.
9. Polsky D: Does Willingness to pay per Quality-Adjusted Life Year Bring us Closer to a Useful Decision Rule for Cost-Effectiveness Analysis? Medical Decision Making 25(6): 605-6, Nov-Dec 2005.
10. Polsky D, Doshi JA, Thompson CE, Paddock S: Differential Loss to Follow-up by Insurance Status in the Health and Retirement Study: Implications for National Estimates on Health Insurance Coverage. Archives of Internal Medicine 165(21): 2537-8; Author Reply 2538, Nov 28 2005.
11. Polsky D: Child neurology: Workforce and Practice Characteristics. LDI Issue Brief 10(6): 1-4, April 2005.
12. Polsky D, Basu A: Selection Bias in Observational Studies. Elgar Companion to Health Economics. Jones, A (eds.). Elgar Press, 2006.
13. Polsky D, Doshi JA, Escarce J, Manning W, Paddock SM, Cen L, Rogowski J: The Health Effects of Medicare for the Near-Elderly Uninsured. National Bureau of Economic Research (NBER) Working Paper 12511, 2006.
14. Roberts CS, Polsky D: Adjustments within Economic Evaluation. Economic Evaluation in U.S. Health Care. Pizzi LT, Lofland JH. (eds.). Sudbury, MA: Jones and Bartlett Publishers Page: 83-100, 2006.
15. Basu A, Polsky D, Manning WG: Use of Propensity Scores in Non-Linear Response Models: The Case for Health Care Expenditures. National Bureau of Economic Research (NBER) Working Paper 14086, 2008.
16. Carpenter DM, Kesselheim AS, Avorn J, Law MT, Polsky D: State Failure-to-Warn Litigation Plays a Critical Role in Ensuring Drug Safety. Amicus curiae brief to the Supreme Court in the case of Wyeth v. Levine, 2008
17. Mandell DS, Morales KH, Marcus SC, Stahmer AC, Doshi J, Polsky D: Are We Overmedicating Our Children?: In Reply. Pediatrics 122(1): 212, July 2008.
18. David G, Polsky D: Economics of Home Health Services. Encyclopedia of Health Economics 1: 477-484, 2014.
19. Polsky D, Weiner J: The Skinny on Narrow Networks in Health Insurance Marketplace Plans. LDI Issue Brief Page 1-5, June 2015
20. Murphy Sean, Polsky D, Meisel Z, Mitchell J: Show Me the Money: Economic Evaluations of Opioid Use Disorder Interventions: LDI/CHERISH Issue Brief Page: 1-5, May 2016.
21. Polsky D, Zhang Y, Yasaitis L, Weiner J: Trends in Physician Networks in the Marketplace in 2016. LDI Issue Brief Page: 1-5, December 2016.
22. McMorrow Stacey, Polsky D: Insurance Coverage and Access to Care Under the Affordable Care Act. LDI Issue Brief 21(2): 1-8, December 2016.
23. Candon M, Polsky D, Saloner B, Wissoker D, Hempstead K, Kenney G, Rhodes K: Primary Care Appointment Availability and the ACA Insurance Expansions. LDI Issue Brief 21(5): 1-4, March 2017.
24. Polsky D, Weiner J, Zhang Y: Narrow Networks on the Individual Marketplace in 2017. LDI Issue Brief 21(8): 1-6, September 2017.
25. Polsky D, Weiner J, Zhang Y: Exploring the Decline of Narrow Networks on the ACA Marketplaces in 2017. LDI Issue Brief 21(9): 1-6, November 2017
26. Candon M, Zuckerman S, Wissoker D, Saloner B, Kenney G, Rhodes K, Polsky D: Declining Medicaid Fees and Primary Care Availability for New Medicaid Patients. LDI Issue Brief 2(10): 1-3, November 2017
27. Zhu J, Polsky D, Zhang Y: State-Based Marketplaces Outperform Federally-Facilitated Marketplaces. LDI Issue Brief 22(1): 1-7, March 2018.
28. Maclean JC, McClellan C, Pesko M, Polsky, D: Reimbursement Rates for Primary Care Services: Evidence of Spillover Effects to Behavioral Health. National Bureau of Economic Research (NBER) Working Paper 24805, July 2018.
29. Polsky D, Catterjee P, Xinwei C, Weiner J: Proposed Work Requirements in Pennsylvania Medicaid: Characterizing Eligible Beneficiaries. LDI Issue Brief 23(1): 1-22, October 2018.
Chapters
1. Neumark D, Polsky D: Has Job Stability Declined Yet? New Evidence for the 1990's. On the job: Is Long-Term Employment a Thing of the Past? Neumark D (eds.). New York: Russell Sage Foundation, Page: Chapter 3 pg. 70-110, 2000.
2. Schulman KA, Glick HA, Polsky D: Pharmacoeconomics: Economic Evaluation of Pharmaceuticals. Pharmacoepidemiology. Strom BL (eds.). New York: John Wiley & Sons, 3: Chapter 35 pg. 573-602, 2000.
3. Glick H, Polsky D, Schulman KA: Trial-Based Economic Evaluations: An Overview of Design and Analysis. Theory and Practice of Economic Evaluation in Health Care. Drummond M, McGuire A. (eds.). London UK: Oxford University Press Chapter 6: 113-140, 2001.
4. Schulman KA, Glick HA, Polsky DA, John KR, Eisenberg JM: Pharmacoeconomics. Drug Benefits and Risks. van Boxtel CJ, Santoso B, Edwards IR (eds.). New York: John Wiley & Sons, Page: Chapter 4 pg. 37-53, 2001.
5. Schulman KA, Glick HA, Polsky D: Pharmacoeconomics: Economic Evaluation of Pharmaceuticals. Pharmacoepidemiology, Fourth Edition. Strom, BL (eds.). New York: John Wiley & Sons, Chapter 42: 629-652, 2005.
PRACTICE ACTIVITIES
Research Findings translation to Inform Policy and Practice
Presentations to policy-makers and other stakeholders
2015 Pennsylvania Health Funders Collaborative’s (PHFC) Ninth Annual Conference, Speaker: Vision and Concepts for Big Data and Positive Deviance Benchmarking, October 2015, Harrisburg, PA
National Roundtable for Dental Collaboration Meeting, American Dental Association, January 2018, Chicago, IL
Consultations with policy-makers and other stakeholders
Pennsylvania Pathway to Better Health and Lower Costs, July 2015, Harrisburg, PA
Competition in Pennsylvania’s Health Insurance Market: Meeting with Pennsylvania’s Insurance Department, September 2015, Harrisburg, PA
Health Innovation in Pennsylvania (HIP) Price and Quality Transparency Work Group, November 2015, Harrisburg, PA
Health Innovation in Pennsylvania (HIP) Price and Quality Transparency Work Group, January 2016, Harrisburg, PA
Rural Health Roundtable Discussion with Governor Wolf, July 2016, Harrisburg, PA
Pennsylvania Insurance Database Stakeholder Workgroup Meeting, August, 2016, Harrisburg, PA
Shoppable Care Work Group, October 2016-July2017, Harrisburg, PA
Governor’s Advisory Board on Health – Healthcare Cost Subcommittee, January 2017-July
Shatterproof and The Pew Charitable Trusts: Substance Use Treatment Task Force Kickoff Meeting, September 2017, Washington, DC
Public Health Summit Policy Chairs, October 2017, Washington, DC
Urban Institute, DC Medicaid Workshop, November 2017, Washington, DC
Roundtable Meeting with Senators Murphy and Merkley, November 2017, Washington, DC
Roundtable Meeting with Andy Slavitt and Senators Bennet and Kaine, February 2018, Washington, DC
Sustainable U.S. Health Spending: Serious Issues – Sound Policy Solutions and Research Consortium, July 2018, Washington, DC
Other practice activities
United States of Care and Leonard Davis Institute of Health Economics Research Partnership, February 2018-present
CURRICULUM VITAE
Daniel E. Polsky, Ph.D., M.P.P.
Part II
TEACHING
Advisees
Doctoral Advisees (University of Pennsylvania Only)
Vicki Chen, Graduated 2018
Thesis title: Paying to Stay: Effects of Vertical Integration and Integration and Competition in a Post-Acute Care Setting
William Pajerowski, Graduated 2017
Thesis title: Physician Behavior in Accountable Care Organizations
Shulamite Chiu, Graduated 2017
Thesis title: The effect of Market Expansions on Provider Treatment Behavior (the Case of Dentistry)
Preethi Rao, Graduated 2016
Thesis title: Hospital Response to Changes in Medicaid Reimbursement
Ari Friedman, Graduated 2016
Thesis title: Firm Response to Low-Reimbursement Patients in the Market for Unscheduled Outpatient Care
Henry Bergquist, Graduated 2015
Thesis title: An Examination of Medical Technology Disadoption and its Relation to Technology Adoption and Physician Organization
Nora Becker, Graduated 2015
Thesis title: Insurance Coverage Mandates for Preventive Care: The Market for Contraceptives
Sunita Desai, Graduated 2015
Thesis title: Health Information Exchange, Interoperability, and Network Effects
Victoria Perez, Graduated 2015
Thesis title: The Effect of Specialty Tier Placement on Enrollment and Utilization in Medicare Part D
Andrea Millman-Drechsler, Graduated 2013
Thesis title: Competition, Ownership Type, and Provider Behavior in the Hospice Industry
Michelle Kim, Graduated 2011
Thesis title: The Effect of Publicized Hospital Charges on Hospital Choice
Andrea Puig, Graduated 2011
Thesis title: The Demand for Preventive Activities and its Association with Medicare Expenditures
Christopher Gingerich, Graduated 2010
Thesis title: Economic Determinants and Consequences of Physical Activity
Eric Keuffel, Graduated 2010
Thesis title: The Impact of Physical Activity on Short-Run Healthcare Utilization and Costs in US Adults
Scott Johnson, Graduated 2006
Thesis title: Physician Agency Issues and Response to FDA Labeling: The Case of Anti-Cancer Drugs
Helena Szrek, Graduated 2005
Thesis title: The Value of Choice in Health Insurance Purchasing
Rachel Werner, Graduated 2004
Thesis title: Testing Theories of Discrimination in Health Care: Evidence from New York’s CABG report Card
Preliminary Oral Participation (University of Pennsylvania Only)
Vicki Chen, Proposal Defense, 2017 (role: committee member)
William Pajerowski, Proposal Defense, 2016 (role: chair/advisor)
Shulamite Chiu, Proposal Defense, 2016 (role: advisor)
Preethi Rao, Proposal Defense, 2015 (role: committee member)
Ari Friedman, Proposal Defense, 2015 (role: committee member)
Henry Bergquist, Proposal Defense, 2014 (role: committee member)
Nora Becker, Proposal Defense, 2014 (role: advisor)
Sunita Desai, Proposal Defense, 2014 (role: committee member)
Victoria Perez, Proposal Defense, 2014 (role: committee member)
Andrea Millman-Drechsler, Proposal Defense, 2012 (role: committee member)
Michelle Kim, Proposal Defense, 2010 (role: committee member)
Andrea Puig, Proposal Defense, 2010 (role: committee member)
Christopher Gingerich, Proposal Defense, 2009 (role: committee member)
Eric Keuffel, Proposal Defense, 2009 (role: committee member)
Scott Johnson, Proposal Defense, 2005 (role: committee member)
Helena Szrek, Proposal Defense, 2004 (role: committee member)
Rachel Werner, Proposal Defense, 2003 (role: committee member)
Final Oral Participation (University of Pennsylvania Only)
Vicki Chen, Thesis Defense, 2018 (role: committee member)
William Pajerowski, Thesis Defense, 2017 (role: chair/advisor)
Shulamite Chiu, Thesis Defense, 2017 (role: advisor)
Preethi Rao, Thesis Defense, 2016 (role: committee member)
Ari Friedman, Thesis Defense, 2016 (role: committee member)
Henry Bergquist, Thesis Defense, 2015 (role: committee member)
Nora Becker, Thesis Defense, 2015 (role: advisor)
Sunita Desai, Thesis Defense, 2015 (role: committee member)
Victoria Perez, Thesis Defense, 2015 (role: committee member)
Andrea Millman-Drechsler, Thesis Defense, 2013 (role: committee member)
Michelle Kim, Thesis Defense, 2011 (role: committee member)
Andrea Puig, Thesis Defense, 2011 (role: committee member)
Christopher Gingerich, Thesis Defense, 2010 (role: committee member)
Eric Keuffel, Thesis Defense, 2010 (role: committee member)
Scott Johnson, Thesis Defense, 2006 (role: committee member)
Helena Szrek, Thesis Defense, 2005 (role: committee member)
Rachel Werner, Thesis Defense, 2004 (role: committee member)
Masters-level Academic Advising (University of Pennsylvania Only)
MSHP (2006-2008): Craig Pollack
MSHP (2006-2008): Giridhar Mallya
MSHP (2008-2010): Marissa Blum
MScHPR (2009-2010): Mark Neuman
MSHP (2009-2010): Josh Hilton
MSHP (2010-2012): Shivan Mehta
MSHP (2012-2014): Samuel Swisher-McClure
Masters Capstone Advising (University of Pennsylvania Only)
Other Mentoring and Research Advising (University of Pennsylvania Only)
Susmita Pati, assistant professor, 2004-2007
Rachel Werner, assistant professor, 2007-2010
Olga Jarin, Claire M. Fagin Fellow, 2012
David Lee, associate professor, 2012-2014
Brendan Saloner, postdoctoral researcher, 2012-2014
Michael Richards, postdoctoral researcher, 2013-2015
Robert Nathenson, postdoctoral researcher, 2013-2015
Ben Ukert, postdoctoral researcher, 2016-2018
Elena Andreyeva, postdoctoral researcher, 2016-2018
Molly Candon, postdoctoral researcher, lecturer, 2016-present
Jane Zhu, assistant professor, 2016-present
Salama Freed, postdoctoral researcher, 2018-present
Liisa Laine, postdoctoral researcher, 2018-present
Austin Bean, postdoctoral researcher, 2018-present
Classroom Instruction
Co-Instructor, MOD320: Health Care System, 2015 – present
University of Pennsylvania School of Medicine, Philadelphia, PA
Instructor, MSHP-HPR612: Health Services and Policy Research Methods II, 2009 – 2012
University of Pennsylvania School of Medicine, Philadelphia, PA
Instructor, HCMG101: Health Care Systems, 2008 – present
The Wharton School, University of Pennsylvania, Philadelphia, PA
Instructor, MSHP-HPR612: Health Services and Policy Research Methods II, 2007
University of Pennsylvania School of Medicine, Philadelphia, PA
Instructor, HCMG101: Health Care Systems, 2005 – 2006
The Wharton School, University of Pennsylvania, Philadelphia, PA
Instructor, HCMG901: Cost-Benefit and Cost Effectiveness Analysis, 2004 - present
The Wharton School, University of Pennsylvania, Philadelphia PA
RESEARCH GRANT PARTICIPATION
Ongoing Research Support
Analyzing the Fully Insured Market, Robert Wood Johnson Foundation, 7/2018-6/2019 (Daniel Polsky, PI), $445,000/annual direct costs, 9% effort (Role in grant: PI)
Baseline Assessment of Payer Strategies to Improve Treatment of Opioid Disorder, Laura and John Arnold Foundation, 5/2018-11/2018 (Daniel Polsky, PI), $199,648/annual direct costs, 10% effort (Role in grant: PI)
The Impact of ACOs on disparities, NIH, 3/2016-2/2020 (Werner, PI), $299,422/annual direct costs, 10% effort (Role in grant: Co-Investigator)
Training in Healthcare Financing, Organization and Delivery for Aging Populations, National Institute on Aging, 8/2015-7/2020 (Pauly, PI: Werner, Co-Investigator), $40,246/annual direct costs (Role in grant: Faculty)
A Randomized Trial of Incentives for Research Participation, NIH, 7/2015-6/2020 (Halpern, PI), $334,756/annual direct costs, 1% effort (Role in grant: Co-Investigator)
Health Economics of Substance Abuse and HCV/HIV Treatment in the Era Integrate, Cornell University, 7/2015-4/2020 (Meisel, PI), $159,862/annual direct costs, 8% effort (Role in grant: Co-Investigator)
Smarter Big Data for Healthy Pennsylvania, PA CURE, 6/2015-5/2019 (Polsky, PI), $1,000,000/annual direct costs, 15% effort (Role in grant: PI)
Testing an Organizational Change Model to Address Smoking in Mental Healthcare, NIH, 3/2015-2/2020 (Schnoll, PI), $350,000/annual direct costs, 3% effort (Role in grant: Co-Investigator)
University of Pennsylvania Prevention Research Center, Centers for Disease Control and Prevention (Cdc), 1-U48-DP-005053-01, 9/2014-9/2019 (KAREN GLANZ, PI), $562,307/annual direct costs, 5% effort (Role in grant: Co-I)
The Penn Violence and Injury Control Research Center, National Center for Injury Prevention and Control/Cdc/Dhhs, 8/2014-7/2019 (Charles C. Branas, PI), $522,109/annual direct costs, 5% effort (Role in grant: Co-I)
Impact of Enhancements to Smartphone-Based Continuing Care for Alcohol Dependence, National Institute on Alcohol Abuse and Alcoholism/Nih/Dhhs, 7/2014-3/2019 (James Robert McKay, PI), $474,169/annual direct costs, 10% effort (Role in grant: Co-I)
Economic Evaluation of Medication-Assisted Substance Abuse Treatment, Cornell University, 14010006-01, 4/2014-3/2018 (Daniel E. Polsky, PI), $232,772/annual direct costs, 10% effort (Role in grant: PI)
Completed Research Support
Delivering Psychosocial Treatment to Substance Abusers Via Mobile Technologies, National Development and Research Institutes, Inc., NDRI Project # 631, 7/2014-6/2015 (Daniel E. Polsky, PI), $18,746/annual direct costs, 2% effort (Role in grant: PI)
RWJ/LDI Health Insurance Exchange Data Briefs, Robert Wood Johnson Foundation, 71662, 2/2014-2/2015 (Daniel E. Polsky, PI), $110,000/annual direct costs, 10% effort (Role in grant: PI)
Primary Care in Philadelphia: Testing Methods to Measure Supply of Primary Care by Neighborhood, Independence Foundation, N/A, 1/2014-12/2014 (DAVID T. GRANDE, PI), $100,000/annual direct costs, 5% effort (Role in grant: Co-PI)
Using an Access-Audit Method to Measure the Impact of The Affordable Care Act on Access to Primary Care, Robert Wood Johnson Foundation, 71100, 12/2013-12/2014 (KARIN V. RHODES, PI), $380,356/annual direct costs, 15% effort (Role in grant: Co-PI)
Generating State-Level Estimates of Primary Care Access for Massachusetts, Blue Cross Blue Shield of Massachusetts Foundation, N/A, 11/2012-12/2014 (KARIN V. RHODES, PI), $108,526/annual direct costs, 20% effort (Role in grant: Co-PI)
Improving Consumer Response to Nursing Home Quality Information: An Evaluation of Composite Measures, Agency for Healthcare Research and Quality (Ahrq), 5-R21-HS-021861-03, 9/2012-8/2015 (RACHEL M WERNER, PI), $203,470/annual direct costs, 10% effort (Role in grant: Co-I)
Effectiveness of Radiotherapy for Prostate Cancer, National Cancer Institute/Nih/Dhhs, 8/2012-7/2017 (JUSTIN BEKELMAN, PI), $162,000/annual direct costs, 5% effort (Role in grant: Co-I)
A Randomized Trial of Urban Vacant lot Stabilization and Substance Abuse Outcomes, NIA/NIAAA, 1 R01 AA020331-01A1, 7/2012-6/2017 (Branas, PI), $1,500,000/annual direct costs, 5% effort (Role in grant: co-investigator)
Advancing Research on Improving Medical Decision Making Among Aging Populations, NIH/NIA, 1R13AG041623-01, 10/2011-9/2014 (Polsky, PI), $39,943/annual direct costs, 1% effort (Role in grant: PI)
Integrating Substance Abuse Assessment and Intervention in Primary Care Settings, Treatment Research Institute, CURE_UPENN, 6/2011-5/2015 (Daniel E. Polsky, PI), $232,772/annual direct costs, 3% effort (Role in grant: PI)
Delaware Valley Node of the National Drug Abuse Treatment Clinical Trials Network NIH/NIDA, U10 DA15815, 9/2010-8/2015 (Woody, PI), $500,000/annual direct costs, 5% effort (Role in grant: co-investigator)
Impact of Medicare Part D in Dual Eligibles with Schizophrenia, AHRQ, 1R01HS018389-01A1, 9/2010-8/2013 (Doshi, PI), $300,000/annual direct costs, 10% effort (Role in grant: Co-investigator)
Advancing Instrumental Variable Methods in Comparative Effectiveness Research, NIH/NCI/IRRA, 1RC4CA155809-01, 8/2010-7/2013 (Basu (Polsky subcontract), PI), $250,000/annual direct costs, 16% effort (Role in grant: PI (subcontract))
Pharmacogenetics of Nicotine Addiction Treatment, NIH/NIDA, 2-U01-DA-020830-06, 7/2010-6/2015 (Lerman/Tyndale, PI), $500,000/annual direct costs, 3% effort (Role in grant: co-investigator)
Evaluating Pay for Performance and its Design: Evidence from Nursing Homes, NIH/NIA, AG 034182, 3/2010-2/2013 (Werner, R., PI), $480,167/annual direct costs, 10% effort (Role in grant: co-investigator)
Improving the Value of Pay-for-Performance: An Evaluation in Hospitals, AHRQ, 1R01HS018409-01, 10/2009-9/2012 (Werner, PI), $213,483/annual direct costs, 10% effort (Role in grant: Co-investigator)
Cardiovascular Device Technologies and Medicare Cost Growth: 2001-2008, AHRQ, 1R01HS018403-01, 9/2009-6/2012 (Groeneveld, PI: Polsky, Co-Investigator), $236,000/annual direct costs, 15% effort (Role in grant: Co-PI)
An Effectiveness Trial of Maintenance Therapy for Nicotine Dependence, NIH/NIDA, 1 R01 DA025078-01, 6/2009-5/2014 (Schnoll, PI), $250,000/annual direct costs, 3% effort (Role in grant: Co-investigator)
Market Competition and The Quality of Home Health Services, National Heart, Lung, And Blood Institute/Nih/Dhhs, 5-R01-HL088586-03, 8/2008-7/2012 (Daniel E. Polsky, PI), $297,474/annual direct costs, 25% effort (Role in grant: PI, score:7.0 percentile)
Impact of Medicaid Prescription Copayments in Patients with Schizophrenia, NIH/NIMH, R01 MH080976, 10/2007-9/2011 (Doshi J, PI), $300,000/annual direct costs, 10% effort (Role in grant: Co-investigator)
Treatment Study Using Depot Naltrexone, NIH/NIDA, R01 DA024553-01A1, 9/2007-8/2012 (O'Brien, PI), $379,760/annual direct costs, 5% effort (Role in grant: Co-investigator)
Implications of Cardiovascular Technology Diffusion among Medicare beneficiaries, NIH/NHLBI, HL086919-01, 6/2007-5/2010 (Groeneveld, P, PI), $349,811/annual direct costs, 18% effort (Role in grant: Co-investigator)
Interstate Variation in Healthcare Utilization Among Children with ASD, NIH/NIMH, R01 MH077000, 5/2007-4/2012 (Mandel, D, PI), $500,000/annual direct costs, 10% effort (Role in grant: Co-investigator)
Novel Application of Infection Control Strategies to Limit Transmission of ESBLS, CDC, 5R01CI000389-03, 10/2006-9/2009 (Lautenbach, PI), $500,000/annual direct costs, 3% effort (Role in grant: Co-investigator)
The Impact of Public Reporting on the Quality of Post-Acute Care, AHRQ, 10/2006-9/2009 (Werner, R, PI), $400,000/annual direct costs, 11% effort (Role in grant: Co-investigator)
Computer-Delivery of Effective, Psychosocial Interventions in Methadone Treatment, National Development and Research Institutes, Inc., R01-DA021818#138, 9/2006-3/2011 (Daniel E. Polsky, PI), $18,551/annual direct costs, 3% effort (Role in grant: PI, 10% FTE next year to perform final economic analysis.)
Employment Interventions for Offenders, NIH/NIDA, R01 DA019600, 7/2006-6/2011 (Coviello, D, PI), $300,000/annual direct costs, 4% effort (Role in grant: Co-investigator)
Promoting Self-Care Using Telehomecare: Impact on Outcomes, National Institutes of Health, 5-R01-NR-008923-04, 9/2005-5/2010 (KATHRYN H BOWLES, PI), $285,726/annual direct costs, 5% effort (Role in grant: Co-PI, Effort of 10% will return in final year of grant for analysis of economic data.)
Individualized Interventions to Improve Asthma Adherence, NIH/NHLBI, 4/2005-3/2010 (Apter, A, PI), $499,000/annual direct costs, 3% effort (Role in grant: Co-investigator)
A New Method of Valuing Investments in Workers' Health, CDC, 10/2004-9/2007 (Nicholson, S, PI), $250,000/annual direct costs, 10% effort (Role in grant: PI of subcontract)
Impact of Iyengar Yoga on Hypertensives, NIA/NCCAM, 10/2004-9/2006 (Szapary, P, PI), $200,000/annual direct costs, 3% effort (Role in grant: Co-investigator)
Lifecycle Effects of Health Insurance on Elderly Health, NIH/NIA, R01-D017221, 9/2004-8/2007 (Polsky D, PI), $334,051/annual direct costs, 20% effort (Role in grant: PI, R01-D017221; score: 2.2 percentile)
Cea In Ctn: Bup/Nal Treatment for Opioid Addicted Youth, National Institutes of Health, 5-R01-DA-017221-03, 8/2004-7/2009 (Daniel E. Polsky, PI), $195,300/annual direct costs, 2% effort (Role in grant: PI, R01-AG024451; score: 7.1 percentile)
VA Merit Review Comparing VA Health Disparities to Health Disparities Outside the VA, VA/HSR&D, 1/2004-6/2006 (Volpp, K, PI), $250,000/annual direct costs, 23% effort (Role in grant: Co-investigator)
Center for Education and Research Therapeutics, AHRQ, 9/2003-8/2008 (Strom, B, PI), $83,738/annual direct costs, 5% effort (Role in grant: Co-investigator)
Continuing Care in Alcohol Treatment, NIH/NIAAA, 9/2003-8/2004 (Oslin, D, PI), $200,000/annual direct costs, 10% effort (Role in grant: Co-investigator)
Decision Support Tools for Nurse Workforce Management: Testing a Model of the International Migration of Nurses to the United States, University Research Foundation, University of Pennsylvania, 7/2003-6/2004 (Polsky D, PI), $20,000/annual direct costs (Role in grant: PI, Internal Pilot with no salary support)
Health Insurance, Health, and Labor Force Participation among Elderly Mexicans, PARC/Boettner Center, University of Pennsylvania, 7/2003-6/2004 (Polsky D, PI), $20,000/annual direct costs, 5% effort (Role in grant: PI)
How Does the Lack of Health Insurance Prior to age 65 Impact Health in old age?, Institute of Aging, 7/2003-6/2004 (Polsky D, PI), $47,453/annual direct costs, 10% effort (Role in grant: PI)
Depression Treatment: Estimating Longitudinal Benefits for Patients, Providers, Plans, and Employers, The Robert Wood Johnson Foundation, 4/2003-3/2004 (Polsky D, PI), $100,000/annual direct costs, 10% effort (Role in grant: PI)
Race, Treatment and Endometrial Cancer Survival, NIH/NCI, 1/2003-12/2005 (Armstrong, K, PI), $0/annual direct costs, 2% effort (Role in grant: Co-investigator)
Generalizability of Health Disparities Research in the VA, VA/CHERP, 5/2002-10/2002 (Volpp, K, PI), $13,740/annual direct costs (Role in grant: Co-investigator, Internal Pilot with no salary support)
Provider Specialty and Outcomes in Ovarian Cancer, NCI, 4/2002-3/2005 (Silber, J, PI), $376,941/annual direct costs, 5% effort (Role in grant: Co-investigator)
Center for Assessment of Drug Abuse Treatment, NIDA, 3/2002-2/2007 (O'Brien, C, PI), $1,744,882/annual direct costs, 5% effort (Role in grant: Co-investigator)
Statistical Methods for Cost Research in Alcohol, NIAAA, 3/2002-9/2005 (Polsky D, PI), $382,912/annual direct costs, 30% effort (Role in grant: PI, R01-AA12665; score: 1.1 percentile.)
Health Plan Choices and Adverse Selection in Employer Sponsored Health Insurance, The Robert Wood Johnson Foundation, 2/2002-7/2003 (Polsky D, PI), $125,000/annual direct costs, 14% effort (Role in grant: PI)
Using Instrumental Variables to Reduce Bias in Observational Studies of Drug Insurance Effects, University Research Foundation, 2/2002-1/2003 (Polsky D, PI), $10,000/annual direct costs (Role in grant: PI, Internal Pilot with no salary support)
Current and Potential Labor Shortages in Child Neurology, Child Neurology Society, 10/2001-9/2002 (Polsky D, PI), $100,000/annual direct costs, 20% effort (Role in grant: PI)
Center for Excellence for Patient Safety Research and Practice, AHRQ, 9/2001-8/2006 (Strom, B, PI), $1,310,902/annual direct costs, 2% effort (Role in grant: Co-investigator)
2H-BD3, Novartis Pharma, 7/2000-6/2002 ( , PI), $100,000/annual direct costs, 16% effort (Role in grant: Co-investigator)
Cost-Effectiveness of Linezolid, Pharmacia/Upjohn Co, 7/1999-6/2001 ( , PI), $275,000/annual direct costs, 46% effort (Role in grant: Co-investigator)
Evolution of HMO's and Risk Selection, The Robert Wood Johnson Foundation, 2/1999-1/2000 (Polsky D, PI), $91,743/annual direct costs, 25% effort (Role in grant: PI)
Integrated v. Referred-out Methadone Treatment: Quality and Costs, The Robert Wood Johnson Foundation, 2/1999-1/2000 (Polsky D, PI), $90,000/annual direct costs, 30% effort (Role in grant: PI)
RAILES, Searle/Adactone, 2/1999-1/2000 ( , PI), $150,000/annual direct costs, 36% effort (Role in grant: Co-investigator)
Cost-Effectiveness Study of Tirilazad in Renal Patients, Pharmacia/Upjohn Co, 11/1998-12/2001 ( , PI), $165,000/annual direct costs, 9% effort (Role in grant: Co-investigator)
Care, Costs, and Outcomes of Local Breast Cancer, Georgetown (Core) AHCPR (Agency), 11/1998-10/2000 (Polsky, D-Subcontract, PI), $200,000/annual direct costs, 25% effort (Role in grant: PI-Subcontract)
Meta-Analysis of Economic Results of Tirilazad Mesylate for Treatment of Subarachnoid, Pharmacia/Upjohn Co, 3/1998-12/1998 ( , PI), $80,906/annual direct costs, 8% effort (Role in grant: Co-investigator)
An Economic Evaluation of Fluoxetine, Paroxetine and Sertraline in an HMO, SmithKline Beecham, 1/1998-12/1998 (Polsky D, PI), $68,778/annual direct costs, 25% effort (Role in grant: PI)
Physician Responses to HMO Growth, The Robert Wood Johnson Foundation, 7/1997-2/1999 (Polsky D, PI), $217,272/annual direct costs, 40% effort (Role in grant: PI)
ACADEMIC SERVICE
Department / School / University
Co-Chair, Health Care Value and Outcomes Sub-Committee of Penn Medicine Strategic Planning Committee, 2017 – present
Member, Consultative Review Committee on the Reappointment of Larry Jameson as Dean of the Perelman School of Medicine, 2017
Member, Medical Ethics and Health Policy Departmental COAP, 2016 - present
Member, Fels Faculty Steering Committee, 2015 – present
Member, Department of Medical Ethics and Health Policy Committee of Academic Appointments, 2014 - present
Member, Center for Public Health Initiatives Advisory Board, 2013 - present
Member, Department of General Internal Medicine Chief Search Committee, 2013
Member, Precision Medicine Steering Committee, 2013 – 2014
Member, Search Committee for Chair of Department of Epidemiology and Biostatistics, 2013 – 2014
Member, University of Pennsylvania Benefits Committee, 2012 – 2014
Member, LDI Center for Health Incentives and Behavior Economics Advisory Board, 2012 - present
Member, Executive Committee and Chair of Curriculum Committee for Masters of Science in Health Policy Research, University of Pennsylvania, 2006 - present
PRESENTATIONS
Scientific Meetings
Program Committee member and Session Chair of conference "Economic Assessment in Clinical Trials: Design and Analysis" sponsored by Drug Information Association
Hilton Head, SC, 11/97
Program committee member and Session Chair of conference "Economic Assessment in Clinical Trials: Design and Analysis" sponsored by Drug Information Association
Orlando, FL, 11/99
Program committee member and Session Chair of conference "Economic Assessment in Clinical Trials: Design and Analysis" sponsored by Drug Information Association
London, England, 02/01
Session Chair of "Transforming Cost Data: When is it Appropriate?" at the 8th Annual Meeting of the International Society Pharmacoeconomics and Outcomes Research
Washington, DC, 05/03
Session Organizer of "Employer and Employee Health Insurance Choices: Implications for Coverage" at the 20th Annual Research Meeting of AcademyHealth
Nashville, TN, 06/03
Session Organizer of "Risk Selection in Public and Private Insurance Markets: Theory and Evidence" at the International Health Economics Association 4th World Conference
San Francisco, CA, 06/03
Session Organizer for "The Effect of Universal Health Insurance on Health" and Session Chair of "Investment in Workers' Health" 5th World Congress of the International Health Economics Association
Barcelona, Spain, 07/05
Session Chair and Discussant on "Economics of Population Health" for the Inaugural Conference of the American Society of Health Economists
Madison, WI, 06/06
Program committee for the 13th NIMH Biennial Research Conference on the Economics of Mental Health: Pharmacoeconomics.
Bethesda, MD, 09/06
Session Organizer of "The Economics of Racial Disparities in Healthcare" at the 6th World Congress of the International Health Economics Association,
Copenhagen, Denmark, 07/07
Workshop Organizer and Director "Clinical Trials Network: Cost-Effectiveness Evaluation in Addiction Treatment" Clinical Trials Workshop
Washington DC, 07/09
Healthcare Program Committee for the Annual Meeting of the Association for Public Policy Analysis and Management
Toronto, CN, 11/09
Session Organizer, "The Economics of Post-Acute Care." Bi-Annual Meeting of the American Society of Health Economists
Ithaca, NY, 11/10
Session Organizer, "The Economics of Home Health." Bi-Annual Meeting of the International Society of Health Economics
Toronto, CN, 08/11
Co-Chair of the 33rd Annual Meeting of the Society for Medical Decision Making
Chicago, IL, 11/11
Co-Chair, 2013 Annual Health Economics Conference
Philadelphia, PA, 11/13
Chair, Improving Oral Hygiene Behavior: A Workshop to Spark New Ideas
Philadelphia, PA, 11/13
Session Organizer, Association for Public Policy Analysis and Management
Washington, DC, 11/13
Chair, American Society of Health Economists
Philadelphia, PA, 06/16
Invited Seminars
"Confidence Intervals for Cost-Effectiveness Ratios: Practical Issues"
Workshop at the 2nd Annual Meeting of the Association of Pharmacoeconomics and Outcomes Research Philadelphia, PA 3/97
"Impact of HMO Penetration on the Practice Location Choices of New Physicians"
Presented at Conference on Physicians and the Changing Health Care Marketplace
Institute of Government and Public Affairs
University of Illinois at Chicago, Chicago, IL, 4/97
"Comparative Analysis of Utility Instruments"
Workshop at the International Clinical Economics Short Course
Washington, DC, 5/97
"Job Stability of the Health Care Industry"
Presented at the 14th Annual Meeting of the Association for Health Services Research
Chicago, IL, 6/97
"Impact of HMP Penetration on the Practice Location Choices of New Physicians"
Presented at the 5th Northeast Regional Health Economics Research Symposium
Newport, RI, 8/97
"Confidence Intervals for Cost Effectiveness Ratios: Practical Issues"
Presented at the Drug Information Association Meeting Assessment in Clinical Trials" Design and Analysis
Hilton Head, SC, 11/97
"Is the Nurse Responsible for Home Health Resource Allocation?"
and
"Confidence Intervals for Cost-Effectiveness Ratios: Are the Bootstrap and Fieller Theorem Methods Dependably Accurate for Small Sample Sizes?"
Presented at the 1997 International Conference on Health Policy Research: Methodologic Issues in Health Services and Outcomes Research
Crystal City, VA, 12/97
"Effects of HMO Growth on the Practice Location Choices of New Physicians"
and
"How has Job Stability Changed? New Evidence and Conflicting Findings"
Presented at the American Economic Association Program of the ASSA meetings
Chicago, IL, 1/98
"Has Job Stability Declined Yet? New Evidence for the 1990's"
Presented at the Russell Sage Foundation's Conference Changes in Job Stability and Job Security
New York, NY, 2/98
"Statistical analysis of economic data from clinical trials"
Workshop at XV Annual Meeting of the International Clinical Epidemiology Network
Queretaro, Mexico, 2/98
"Job Stability in the United States"
Presented at the Seminar Series of the Economics Department of Trinity College
Dublin, Ireland, 4/98
"Issues of Generalizability in Cost-Effectiveness Analysis"
Session III
Economic Analysis
Methods of Outcomes research in Hepatology
Precourse at the Annual Meeting of the American Association for the Study of Liver Diseases
New Orleans, LA, 5/98
"Confidence intervals and acceptability for cost-effectiveness ratios"
and
"Multivariable estimation of costs for cost-effectiveness analysis"
Short course 4
Prospective Economic Evaluation of Clinical Trials: Methods and Analysis
Presented at the 20th Annual Meeting of the Society of Medical Decision Making
Boston, MA, 10/98
"Pharmacoeconomics: Basis of Economic Analysis"
Presented at the Gastroenterology Research Group Workshop Symposia: Methodologies in Healthcare Outcomes in Gastroenterology
Tampa, FL, 11/98
"Analysis of Costs in Clinical Trials with Extensive Dropout: AIDS Trials"
Presented at the Drug Information Association Meeting Economic Assessment in Clinical Trials: Design and Analysis
New Orleans, LA, 11/98
"Advanced Markov Modeling Using DATA 3.5"
Presented at the Pre-Meeting Workshop on Decision Analysis at the Global Meeting INCLEN XVI
Bangkok, Thailand, 3/99
"Return to Previous Activity Following Severe Subarachnoid Hemorrhage: Effects of Tirilazad Mesylate Observed in Four Clinical Trials"
Presented at the 1999 American Association of Neurological Surgeons Annual Meeting
New Orleans, LA, 4/99
"HMO Penetration and the Geographic Redistribution of Generalists and Specialist Physicians,"
"HMO's and Risk Selection,"
and
"Impact of HMO Penetration on Physicians' Decisions to Relocate Teir Practices and Leave Patient Care"
Presented at the Association for Health Services Research 16th Annual Meeting
Chicago, IL, 6/99
"Physicians Response to HMO Penetration: Do They Move or Quit Patient Care?"
Presented at the International Health Economics Association 2nd World Conference
Rotterdam, the Netherlands, 6/99
"Estimating Medical Costs for Incomplete Follow-Up Data When Data Are Not Missing Completely at Random"
Presented at the 15th Annual Meeting of the International Society of Technology Assessment in Health Care
Edinburgh, United Kingdom, 6/99
"Statistical Issues in Cost Estimation in Randomized Clinical Trials"
Short Course 5
Prospective Economic Evaluation of Clinical Trials: Methods and Analysis
and
"Estimating Medical Cost for Incomplete Follow-Up Data When Data are Not Missing Completely at Random"
Presented at the 21st Annual Meeting of the Society for Medical Decision Making
Reno, Nevada, 10/99
"Assessing the Uncertaintity of the Economic Results of Randomized Controlled Trials"
Tutorial at the Drug Information Association Meeting Introduction to Designing and Analyzing Economic Assessments in Clinical Trials
Orlando, FL, 11/99
"Identifying the Impact of a Treatment on Outcomes and Costs Using Observational Data: Overcoming Selection Bias"
Workshop at the 5th Annual Meeting of the International Society for Pharmacoeconomics and Outcomes Research
Arlington, VA, 5/00
"HMO's and Risk Selection"
Presented at the 7th Northeast Regional Health Economics Research Symposium
Newport, RI, 8/00
"Estimation of Costs in Randomized Clinical Trials"
Short Course 3
Prospective Economic Evaluation of Clinical Trials: Methods and Analysis
21st Annual Meeting of the Society for Medical Decision Making
Reno, Nevada, 9/00
"Use of Instrumental Variables with SEER-Medicare Data"
Presented at the SEER-Medicare Data Users Workshop
National Cancer Institute
Bethesda, Maryland, 11/00
"HMO Penetration and Geographic Mobility of Practicing Physicians"
Presented at the American Economic Association Annual Meeting joint session with Health Economics Research Organization
New Orleans, Louisiana, 1/01
"Estimating Cost-Effectiveness in Multinational Clinical Trials." Health Economics Research Center and Oxford Medical Statistics Network Meeting Statistical Methods for Cost-Effectiveness Analysis: Recent Developments and Future Directions. St. Anne's College, Oxford University, Oxford, England, 2/01
"Estimating Medical Costs When Follow-Up Data Are Incomplete"
Presented at the Drug Information Association Meeting Economic Assessments in Clinical Trials: Design and Analysis
London, England, 2/01
"Estimating Cost-Effectiveness in Multinational Clinical Trials"
Presented at the Health Economics Research Center and Oxford Medical Statistics Network Meeting Statistical Methods for Cost-Effectiveness Analysis: Recent Developments and Future Directions
St. Anne's College
Oxford University
Oxford, England, 2/01
"An Instrumental Variable Cost Effectiveness Analysis of Breast Cancer Treatments in the Elderly"
Presented at the Wisconsin Network for Health Policy Research Seminar Series
Department of Preventive Medicine
University of Wisconsin
Madison, WI, 4/01
"Identifying the Impact of a Treatment on Outcomes and Costs Using Observational Data: Overcoming Selection Bias." 6th Annual Meeting of the International Society for Pharmacoeconomics and Outcomes Research. Arlington, VA, 5/01
"Identifying the Impact of a Treatment on Outcomes and Costs Using Observational Data: Overcoming Selection Bias"
Workshop at the 6th Annual meeting of the International Society for Pharmacoeconomics and Outcomes Research
Arlington, VA, 5/01
"Estimating Treatment Costs in Randomized Trials"
Presented at Postconference Workshop Implementing Technology Assessment: Training for Those Who Practice Technology Assessment to Train Others
at the 17th Annual meeting of the International Society of Technology Assessment in Health Care
Plymouth Meeting, PA, 6/01
"Estimating Treatment Costs in Randomized Trials." Postconference Workshop Implementing Technology Assessment: Training for Those Who Practice Technology Assessment or Train Others. 17th Annual meeting of the International Society of Technology Assessment in Health Care. Plymouth Meeting, PA, 6/01
"Comparing Instrumental Variable and Propensity Scores Analysis of Outcomes of Localized Breast Cancer Treatments in the Medicare Population." and "Methods for the Analysis of Costs in Observational and Randomized Studies." International Health Economics Association 3rd World Conference. York, England, 7/01
"Estimation of Costs in Randomized Clinical Trials." Short Course 3, Prospective Economic Evaluation of Clinical Trials: Methods and Analysis. 23rd Annual Meeting of the Society for Medical Decision Making. San Diego, California, 10/01
"Estimation of Costs in Randomized Clinical Trials"
Short Course 3
Prospective Economic Evaluation of Clinical Trials: Methods and Analysis
23rd Annual Meeting of the Society of Medical Decision Making
San Diego, California, 10/01
"Why are Managed Care Plans Less Expensive: Risk Selection, Utilization or Reimbursement?"
Presented at the Weill Medical College of Cornell University
New York, NY, 3/02
"Employer-Sponsored Health Insurance and the Uninsured" Invited lecture at the School of Social Work Columbia University, New York, NY, 2/03
"Designing a Cost Study of ADM Services in the Context of a Randomized Design" Presented at a conference entitled "Expanding Mental Health, Drug and Alcohol Services Research Outside the Specialty Care System"
sponsored by the National Institute of Mental Health, the National Institute on Drug Abuse, and the National Institute on Alcohol Abuse and Alcoholism, Bethesda, MD, 3/03
"Health Plan Choices from Employers and Employee Contributions: The Impact on Take-up and Insurance Coverage" Presented at the 20th Annual Research Meeting of AcademyHealth, Nashville, TN, 6/03
"Analysis of Costs Using Patient-Level Data from Random Designs"
Short course delivered at the 20th Annual Research Meeting of AcademyHealth. Nashville, TN, 6/03
"The Microeconomics of Physician Shortages: The Sources of Disequilibrium"
Presented at the International Health Economics Association 4th World Conference, San Francisco, CA, 6/03
"Prospective Economic Evaluation of Clinical Trials: Methods and Analysis." Short Course #7. 25th Annual Meeting of the Society for Medical Decision Making. Chicago, IL, 10/03
"Employer Health Plan Offers and Enrollment Decisions." RAND Health Services Research Group. Washington, DC, 2/04
"Bringing the Economist on Board: Design Issues." The Center for Mental Health Services & Criminal Justice Research First Biennial Conference on Reentry to Recovery: People with Mental Illness Coming Home from Prison or Jail. Philadelphia, PA, 4/04
"Resource Costing in Clinical Trials." and "Cost Attribution in Economic Evaluation: What Is Signal and What Is Noise?" 9th Annual International Meeting of the International Society for Pharmacoeconomics and Outcomes Research. Arlington, VA, 5/04
"Evaluating New Drugs Using Cost-Effectiveness Analysis." Second National Institutes of Mental Health (NIMH) Pharmacoeconomics Research Directions Workshop. Washington, DC, 5/04
"Long-term Risk for Depressive Symptoms After Disease Diagnosis" Complexities of Co-occurring Conditions: Harnessing Services Research to Improve Care for Mental, Substance Use, and Medical/Physical Disorders. Washington, DC, 6/04
"Explaining Differences in Chemotherapy Utilization in Ovarian Cancer Between Health Service Areas." 40th Annual Research Meeting of the American Society of Clinical Oncology. New Orleans, LA, 6/04
"Welcome Home: How Mexican Migrants Miss Out on Retirement Benefits" 21st Annual Research Meeting of AcademyHealth, San Diego, CA, 6/04
"Cost-Effectiveness Research in the CTN." Clinical Trials Network National Steering Committee Meeting. Detroit, MI, 9/04
"Implementing the Institute of Medicine (IOM) Definition of Disparities: Outpatient Mental Health Care" by Thomas McGuire. Discussant at the Twelfth NIMH Biennial Research Conference on the Economics of Mental Health. Washington, DC, 9/04
"Cost-Effectiveness Research for Adolescent Treatment." 2005 Joint Meeting on Adolescent Treatment Effectiveness. Washington, DC, 3/05
"Statistical Considerations in Economic Evaluations." Pre-conference Course. 10th Annual Meeting of the International Society for Pharmacoeconomics and Outcomes Research. Washington, DC, 5/05
"Issues in Cost Effectiveness Analysis." and "Generosity of Retiree Drug Benefits and Essential Medication Use among Aged Medicare Beneficiaries with Employer-Sponsored Health Insurance." 22nd Annual Research Meeting of AcademyHealth. Boston, MA, 6/05
"Cost Utility in Drug Abuse Treatment Evaluation", 5th World Congress of the International Health Economics Association. Barcelona, Spain, 7/05
"Lifecycle Effects of Health Insurance on Elderly Health." Johns Hopkins Bloomberg School of Public Health. Health Policy and Management. Baltimore, MD, 9/05
"Does Medicare at 65 Improve the Health of the Uninsured" Department of Public Health, Weill Medical College. Cornell University, New York, NY, 10/05
"Prospective Economic Evaluation of Clinical Trials: Methods and Analysis." Short Course #7. 27th Annual Meeting of the Society for Medical Decision Making. San Francisco, CA, 10/05
" Lifecycle Effects of Health Insurance on Elderly Health." Yale School of Public Health. Health Management. New Haven, CT, 10/05
"Does Medicare at 65 Improve the Health of the Uninsured" Johns Hopkins Bloomberg School of Public Health. Baltimore, MD 11/05
"Does Medicare at 65 Improve the Health of the Uninsured?" Center for Health Economic and Policy Studies Seminar Series. Department of Health Administration and Policy at the Medical University of South Carolina. Charleston, SC, 1/06
"Racial Health Disparities: A Comparison of Outcomes from Inpatient Admission in VA and Non-VA Hospitals" Chicago Center of Excellence in Health Promotion Economics, University of Chicago, Chicago, IL, 1/06
"Hospital Mortality for Elderly Whites and Blacks: Do hospitals contribute to the lower life expectancy of elderly Blacks?" Chicago Center of Excellence in Health Promotion Economics, University of Illinois at Chicago, Chicago, IL, 1/06
"The Health Effects of Health Insurance on the Near-Elderly Uninsured." National Bureau of Economic Research (NBER) Joint Health Economics Monthly Seminar Series. New York, NY, 2/06
"Statistical Considerations in Economic Evaluations" Pre-conference short course. 11th Annual Meeting of the International Society for Pharmacoeconomics and Outcomes Research. Philadelphia, PA, 5/06
"Economic Assessments in Randomized Trials." Workshop. 23rd Annual Research Meeting of AcademyHealth. Seattle, WA, 6/06
"Evaluating Sample Uncertainty in Cost-effectiveness Analysis." Panel on Issues in Cost-effectiveness Analysis. 23rd Annual Research Meeting of AcademyHealth. Seattle, WA, 6/06
"Cost-Effective Treatment for Adolescents with Opioid Dependence." Inaugural Conference of the American Society of Health Economists: Economics of Population Health. Madison, WI, 6/06
"Discussant of Alcohol Availability and Alcohol Consumption: New Evidence from Ontario's "Blue Law" Repeal." Health Economics Interest Group Meeting. Seattle, WA, 6/06
"The Health Effects of Health Insurance for the Near-Elderly Uninsured." HERO session on Health and Aging: Baby Boomers Becoming Senior Citizens. The 2007 Annual Convention Allied Social Science Associations. Chicago, IL, 1/07
"Statistical Considerations in Economic Evaluations" Pre-conference short course. 12th Annual Meeting of the International Society for Pharmacoeconomics and Outcomes Research. Philadelphia, PA, 5/07
"The Mortality Effects of Health Insurance for the Near-Elderly Uninsured." Health Economics Workshop, Irving B. Harris Graduate School for Public Policy, University of Chicago, Chicago, IL 5/07
"Methods in Cost Effectiveness Analysis." 24th Annual Research Meeting of AcademyHealth. Orlando, FL, 6/07
"Selection bias in Economic Evaluation with Observational data," 6th World Congress of the International Health Economics Association. Copenhagen, Denmark, 7/07
"Short- and Long-Term Mortality after Acute Illness for Whites and Blacks," 6th World Congress of the International Health Economics Association. Copenhagen, Denmark, 7/07
"Potential Gains in Education Attainment from Treating Adolescent Drug Dependence." 6th World Congress of the International Health Economics Association. Copenhagen, Denmark, 7/07
"What Does the Policy World Need from CNS Clinical Trials Researchers?" 4th Annual Scientific Meeting of the International Society for CNS Clinical Trials and Methodology, Washington, DC, 3/08
"Analysis of the Cost-effectiveness of Social Benefits of Buprenorphine/Naloxone Facilitated Rehabilitation for Opioid Dependent Adolescents and Young Adults" Bi-annual meeting of the American Society of Health Economists, Durham, NC, 6/08
"The Marketing Model, Supplier Induced Demand, and Occam's Razor" Discussant. Bi-annual meeting of the American Society of Health Economists, Durham, NC, 6/08
"Methods in Cost Effectiveness Analysis." 25th Annual Research Meeting of AcademyHealth. Washington, DC, 6/08
"Comparative Effectiveness in Practice and Policy" Annual meeting of the Society of Medical Decision Making, Philadelphia, PA, 10/08
"Cost-effectiveness of Extended Buprenorphine/Naloxone Treatment for Opioid Dependent Youth: Data from a Randomized Trial", University of Miami, Miami, FL, 11/08
"Cost-effectiveness of Extended Buprenorphine/Naloxone Treatment for Opioid Dependent Youth: Data from a Randomized Trial", NIDA/CTN Steering Committee, 3/09
"Cream-Skimming of Low-Risk Patients after Initiation of Public Reporting: Evidence from Nursing Homes.' 26th Annual Research Meeting of AcademyHealth. Chicago, IL, 6/09
"What Drives Nursing Home Quality Improvement Under Public Reporting?' 26th Annual Research Meeting of AcademyHealth. Chicago, IL, 06/09
"Methods in Cost Effectiveness Analysis." 26th Annual Research Meeting of AcademyHealth. Chicago, IL, 6/09
"Cost-effectiveness of Extended Buprenorphine/Naloxone Treatment for Opioid Dependent Youth: Data from a Randomized Trial", Cost-Effectiveness Evaluation in Addiction Treatment Clinical Trials Conference. Washington, DC, 7/09
"Planning for Cost-Effectiveness Analyses in Randomized Clinical Trials." Ninth Annual OBSSR/NIH Summer Institute on Randomized Clinical Trials Involving Behavioral Interventions. Warrenton, VA, 7/09
"Health Care Utilization in Medicare Among the Previously Uninsured." Penn State Health Care Administration Seminar. State College, PA, 9/09
"Cost-effectiveness of Extended Buprenorphine/Naloxone Treatment for Opioid Dependent Youth: Data from a Randomized Trial." New Developments in Addiction Treatment, Philadelphia Health Management Corporation. Philadelphia, PA, 9/09
"Health Care Policy Process in the White House: Lessons Learned from the CEA." Health Policy Orientation. AcademyHealth. Washington DC, 10/09
"Economic Evaluation of Clinical Trials: Methods and Analysis." Short Course. Annual Meeting of the Society for Medical Decision Making. Los Angeles, CA, 10/09
"Health Service Use among the Previously Uninsured: Is Subsidized Health Insurance Enough?" Health Policy Seminar Series at George Washington University. Washington DC, 4/10
"Issues in Cost Effectiveness Analysis." 27th Annual Research Meeting of AcademyHealth. Boston, MA, 6/10
"Informing Medicare Policy Through Health Services Research: Employing National Survey-Medicare Claims Linked Data: Health Service Use among the Previously Uninsured." 27th Annual Research Meeting of AcademyHealth. Boston, MA 6/10
"Risks and Prices: The Role of User Sanctions in Marijuana Markets" Discussant. Bi-Annual Meeting of the American Society of Health Economists, Ithaca, NY 6/10
"The Cost and Quality Implications of Certificate of Need in Home Health Care." Bi-Annual Meeting of the American Society of Health Economists, Ithaca, NY 6/10
"Demystifying the Federal Grant Review Process" 28th Annual Research Meeting of AcademyHealth. Seattle, WA 6/11
"Issues in Cost Effectiveness Analysis." 28th Annual Research Meeting of AcademyHealth. Seattle, WA, 6/11
"Cost and Quality Implications of Certificate of Need in Home Health." Biannual meeting of the International Health Economics Association, Toronto, CN, 7/11
"Clinical Workforce." Health Care Speaker Series for the Deputy Secretary and VA Leadership. Washington DC, 8/11
"Competition in Home Health Care" Empirical Economics Workshop, Rice University, Houston, TX, 2/12
"15th Annual Notebaert Lecture", The Children's Hospital of Philadelphia, Philadelphia, PA, 10/13
"Implementing Contingency Management Techniques in a Community Treatment Program", AAAP 24th Annual Meeting and Symposium, Scottsdale, AZ, 12/13
"Appointment Availability after Increases in Medicaid Payments for Primary Care", American Academy of Family Physicians, Washington, DC, 1/15
"Appointment Availability after Increases in Medicaid Payments for Primary Care", Office of the Assistant Secretary for Planning and Evaluation, Washington, DC, 1/15
"The Philadelphia Story: Transforming Healthcare Enabling Providers to Manage Risk", Wharton Alumni Association, Philadelphia, PA, 5/15
"Payment Challenges and Opportunities", National Governors Association, Harrisburg, PA, 7/15
"Physician Narrow Networks in the Health Insurance Marketplace", Office of the Assistant Secretary for Planning and Evaluation, Washington, DC, 10/15
"How Much Do Health Insurance Exchange Consumers Save on Their Premium When They Purchase a Narrow Network Plan?", Yale University, New Haven, CT, 3/16
"Health Care Reform and the Primary Care Physician Labor Market", Johns Hopkins University, Baltimore, MD, 10/16
"Cost-Effectiveness of Depot Naltrexone to Prevent Relapse Among Criminal-Justice-Involved Persons with a History of Opioid Use Disorder", Center for Studies of Addiction University of Pennsylvania, Philadelphia, PA, 10/16
"ACA Insurance Expansions and Primary Care Access", Johns Hopkins University, Baltimore, MD, 4/18
"Scope of Primary Care Physician Participation in Health Insurance Exchange Plans", University of Chicago, Chicago, IL, 4/18
“Volume to Value and the Invisible Gorilla,” Health Spending Symposium, Altarum Center for Value in Health Care. Washington, DC, 7/19
................
................
In order to avoid copyright disputes, this page is only a partial summary.
To fulfill the demand for quickly locating and searching documents.
It is intelligent file search solution for home and business.
Related searches
- johns hopkins university interactive map
- johns hopkins university departments
- johns hopkins university corona dashboard
- johns hopkins university health system
- johns hopkins university portal
- johns hopkins university investment office
- johns hopkins university baltimore address
- johns hopkins university contact
- johns hopkins university phd nursing
- johns hopkins university email
- johns hopkins university communication
- johns hopkins university business analytics